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Abstract
FIBRONECTIN MECHANICS AND SIGNALING IN TGF-β1-INDUCED EPITHELIAL TO
MESENCHYMAL TRANSITION
By Lauren A. Griggs, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy in Biomedical Engineering at Virginia Commonwealth University.
Virginia Commonwealth University, 2018.
Director: Dr. Christopher Lemmon, Ph.D.
Associate Professor, Biomedical Engineering
Epithelial to Mesenchymal Transition (EMT) is a dynamic process by which a distinct
change in the phenotype and function of epithelial cells render them as mesenchymal
cells. Characteristics of mesenchymal cells include the ability to invade, increased
migratory kinetics and heightened resistance to apoptosis. Therefore, there is a strong
need to fully understand the mechanism for the induction of EMT in pathological
conditions such as carcinoma progression. Recent advances highlight two pivotal
contributors, soluble growth factor (gf) signals, and mechanical signals, in the process.
However, to date, no clear mechanism exists linking the two in epithelial
transdifferentiation. Transforming Growth Factor-β1 (TGF-β1), a gf known to induce EMT
in breast cancer formation, induces EMT on rigid surfaces and apoptosis on compliant
surfaces. It is our belief that a combination of mechanical signals, gf signals, and the type
of extracellular matrix (ECM) proteins assembled by cells together drive the process of
EMT. Here we investigated the role of the ECM protein fibronectin (FN) in EMT. Upon
assembly into elastic, insoluble fibrils through cell-generated forces which become larger
on stiffer surfaces, FN is able to serve as a gf delivery system. We examined the following
xvii

hypothesis: Increased tissue stiffness drives FN assembly, which exposes cryptic binding
sites for various gfs, such as TGF-β1, and creates a high concentration of these gfs at
the cell surface, which in turn drives EMT. In this project we investigated three aims: (1)
evaluate the effect of inhibiting FN fibrillogenesis and gf localization on TGF-β1-induced
EMT, (2) assess the effect of TGF-β1 concentration on spatial patterning of ECM
dynamics, cell phenotype and adherens junctional force, and (3) probe the role of the FN
matrix in TGF-β1-induced spatial patterning of EMT. Results showed that both inhibition
of FN fibril assembly and blocking the gf binding site on fibrils significantly attenuated the
downstream effects of EMT. In microcontact patterns of epithelial colonies, increasing gf
concentration led to spatial patterning of FN fibrils, cell phenotype and cell-cell junctional
force. Elimination of FN fibrils effectively attenuated TGF-β1-induced spatial patterning.
The knowledge acquired through these studies serves as an addition to an increasingly
important body of work aimed at elucidating how physical changes within the
microenvironment regulate physiology and pathology. By establishing a novel mechanism
by which gf signaling induces EMT through interaction with the extracellular matrix, this
research serves to combat the development and initiation of pathological phenomena,
such as metastasis.
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1.1 A Rationale for This Study .......................................................................... 2
1.2 Objectives ..................................................................................................... 4
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1.1 A Rationale for This Study
Epithelial to Mesenchymal Transition (EMT) is a morphogenetic process characterized by
a phenotypic shift in epithelial cell monolayers to motile and oftentimes invasive
mesenchymal cells [1, 2]. This tightly regulated process is fundamental in the generation
of new tissues and organs during embryogenesis, and is a key factor in tissue remodeling
and wound healing [3-5]. Although the process is fundamental in development, EMT can
also be misregulated, leading to its implication in several disease states, including cancer
and organ fibrosis [6-8]. A diverse array of factors have been shown to affect EMT, some
of which include soluble signals (i.e. growth factors (gfs) and cytokines) [9-12] and
mechanical stress [13-15], which modulates this process and defines the spatial location
at which it will occur [16]. Expression of Transforming Growth Factor-β1 (TGF-β1) is
significantly increased in human mammary epithelial cell models during EMT and has
been highlighted for its prominent role in inducing EMT [11, 12, 17-19]. While many recent
studies have emphasized the importance of mechanical signaling in cellular events [20,
21], it is not entirely clear how the combination of mechanical and soluble signals trigger
this complex transdifferentiation in pathology.

One particularly attractive target for mechanical-chemical signal integration is the ECM
protein fibronectin (FN) because of its ability to mediate cellular interactions in the
extracellular matrix (ECM). Due to its highly promiscuous gf binding domain, FN has been
suggested to function as a gf delivery system and, as such, has been shown to aid in
various cell-signaling events [22]. Of particular interest is the Latent TGF-β Binding
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protein (LTBP-1), the inactive form of TGF-β1, which has been shown to integrate into
the FN matrix [23-25]. This dissertation highlights FN fibril assembly as a key component
in driving the process of EMT.

There has been a recent surge in research aimed at understanding the role of EMT in
facilitating the progression of breast cancer to an invasive disease [26-30]. Some
literature points to the idea that epithelial cancer cells utilize the EMT circuitry to
delaminate from the primary tumor, invade the blood-stream and form secondary tumors
in distant sites [31-33]. Other studies have challenged this, pointing to EMT as a mediator
of chemoresistance and not cancer metastasis [34, 35]. Our work demonstrates that
exposing mammary epithelial cells to TGF-β1

significantly upregulated

both

mesenchymal cell marker expression and FN fibril assembly. Inhibition of FN fibril
assembly blocked this increase in mesenchymal cell marker expression and maintained
epithelial cell marker expression, suggesting a strong correlation between FN fibril
assembly and TGF-β1-induced EMT.

The foundation of this work is to combat misregulated processes such as cancer
metastasis. The characteristics of EMT, including its hallmarks, and types of EMT will be
outlined in Chapter 2. We will also discuss how EMT is utilized in both development and
disease. A brief overview of the biochemical signaling and biomechanical signaling will
segue into how the ECM is involved in EMT. The background described here serves as
a foundation for our hypothesized mechanism integrating the ECM protein FN in the
induction of EMT. In the next three chapters, we expand upon three phases of our
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research. These studies combine to define the main objective of this work, which is to
investigate whether FN fibrils serve as an integration point for mechanical and chemical
signals in TGF-β1-induced EMT.

1.2 Objectives
Evaluate the effect of inhibiting FN fibrillogenesis and gf localization on TGF-β1induced EMT. While previous studies have demonstrated that FN mRNA levels and
protein expression are both upregulated in response to TGF-β1 [36-39], it is not clear
whether this translates into increased assembly of FN fibrils. Therefore, we hypothesized
that: increased contractile forces drive FN fibril assembly, which exposes cryptic binding
sites for various gfs, such as TGF-β1, and creates a high concentration of binding sites
at the cell surface (Fig. 1A). Through 1) inhibition of FN fibrillogeneisis and 2) blocking
localization of TGF-β1 to FN fibrils via a monoclonal blocking antibody against the
heparin-binding domain of FN, we determined that FN fibril assembly is required for the
induction of EMT and downstream effects. We established a methodology to define the
role of FN fibril assembly in EMT by which we induced EMT with TGF-β1 and analyzed
the expression and localization of several prominent epithelial makers, mesenchymal
markers, and FN through immunofluorescence (IF) and Western blotting. Details on how
this work elucidates the mechanism by which gfs localize to the ECM regulates the
induction of EMT are discussed in Chapter 3.

Assess the effect of TGF-β1 concentration on spatial patterning of ECM dynamics,
cell phenotype, and adherens junctional force. Previous research points to the fact

4

Figure 1.1. Integration of TGF-β1 signaling and FN assembly in the induction of
EMT. (A) FN fibrils serve as a link between substrate and cell. (1) FN, shown in green,
exists in its soluble form surrounding the cell. (2) FN is mechanically stretched into
insoluble fibrils and adheres to integrins, shown in orange, on cell surface. (3) TGF-β1
shown in yellow, is able to bind to gf binding site on the FN fibril, shown in pink, and is
therefore concentrated underneath its cell-surface receptors, shown in blue. (4) TGF-β1
then induces EMT.

5

Figure 1.1

6

that endogenous mechanical stress occurs primarily at the edges of sheets of epithelial
cells as compared to the center, and that such stress leads to spatial patterning of EMT
[16, 20]. We have seen that assembly of new matrix is amplified at the edge of a
monolayer of cells, which correlates with the upregulation of EMT markers. Therefore, we
hypothesized that: a colony of cells cultured on microcontact printed patterns of ECM
proteins and/or TGF-β1 will preferentially assemble FN fibrils at the edges, leading to
EMT primarily around the periphery of the colony. In Chapter 4, we discuss the
methodology behind microcontact printing and effects of TGF-β1 concentration on spatial
patterning of FN dynamics, endogenous latent TGF-β1 colocalization with FN fibrils, cell
number, cell shape, E-cadherin/N-cadherin switch, and adherens junctional force within
square islands.

Probe the role of the FN matrix in TGF-β1-induced spatial patterning of EMT. The
findings from Chapter 4 suggested a correlation between FN fibril assembly and cell
phenotype based on location within square islands. We hypothesized that FN fibrils
localized endogenous latent TGF-β1 primarily at corners and edges in square islands,
leading to restriction of morphological changes to these areas. Results of blocking FN
fibril assembly in microcontact printed patterns showed that epithelial cells were
prevented

from

undergoing

spatially

patterned transformation

with

increasing

concentrations of TGF-β1. Culturing cells on square islands with bound TGF-β1 at various
surface concentrations and in the absence of FN fibrils induced transformation throughout
the entire colony, eliminating spatial patterning. These results suggest that TGF-β1-
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induced spatial patterning relies heavily on gf localization to the FN matrix and are
presented in Chapter 5.

In combination, the work presented in this dissertation illuminates the critical role of the
FN matrix in integrating gf signaling to induce EMT. The impact of this work goes beyond
the process of EMT and has the potential to explain how mechanical and biochemical
signals integrate in diseases such as tissue fibrosis and cancer metastasis, as well as
within developmental processes. Implications of the findings from the three phases of
experimentation outlined in this dissertation, as well as possible future directions, are
discussed in Chapter 6.
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2.1 Characteristics of Epithelial to Mesenchymal Transition
In multicellular organisms, epithelial cell sheets serve as a protective barrier from the
external environment, lining cavities and organs throughout the body. However, when
these cells transdifferentiate into mesenchymal cells, they begin to fill interstitial spaces,
driving the growth and assembly of new tissues [3-5]. Epithelial cells exhibit strong cellcell adhesions, an apicobasal-polarized distribution of organelles and cytoskeleton
components, and cortical actin surrounding the cell periphery. Upon induction of EMT, a
continuous monolayer of cuboidal epithelial cells disassembles its adherens junctions and
transforms into spindle-like, elongated mesenchymal cells [8]. This transition is
accompanied by a switch to front/back polarity that allows the cells to migrate [40, 41].
Once epithelial cells enter an intermediate state between epithelial and mesenchymal
phenotypes, they gain enhanced migratory capacity, increase invasiveness, enhance
angiogenesis close to the tumor microenvironment [42], resist apoptosis, and begin to
increase their production of ECM proteins and fibers [32]. Biomarkers associated with
EMT include cell surface markers such as E-cadherin and N-cadherin, integrins,
cytoskeletal markers such as keratins, vimentin and α-smooth muscle actin, ECM proteins
such as FN, transcription factors such as Snail and Twist, which primarily suppress Ecadherin expression, and MicroRNAs [43, 44].

To date, there are three distinct classifications of EMT. Type I occurs during
embryogenesis and organ development. Cells undergoing type I EMT are responsible for
the formation of the three germ layers, which allow for the generation of all tissues in the
body. Type II occurs during wound healing or organ fibrosis, and is signaled by an
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inflammatory response. Type II EMT has been implicated in cirrhosis [45, 46] and kidney
fibrosis [47, 48]. Type III EMT, which is the focus of the work presented here, is associated
with cancer metastasis [49-51].

2.2 Biochemical Overview of EMT
EMT is induced primarily through soluble gf signaling, including TGF-β1 [11, 12, 17-19],
epidermal growth factor (EGF) [10, 52], fibroblast growth factor (FGF), hepatocyte growth
factor (HGF), platelet-derived growth factor (PDGF), Jagged, Delta-like and Wnt ligands
[9, 20]. The process is regulated through several prominent signaling mechanisms. The
primary signaling pathway is that of TGF-β. Briefly, upon secretion from the cell, TGF-β
ligands bind to TGF-βRII receptors on the cell surface, which initiates a phosphorylation
cascade. TGF-βRII phosphorylates TGF-βRI, and R-Smads (Smads 2 and 3) are then
recruited to form a heteromeric complex with co-Smad (Smad 4). This complex is then
able to translocate to the nucleus, where it acts as a transcription factor, regulating the
expression of various epithelial and mesenchymal cell associated proteins [53, 54]. The
Smad-independent pathways, which also directly enhance and contribute to TGF-β1induced EMT, include the Ras-Extracellular Signal-Regulated Kinase (ERK)-Mitogenactivated kinase (MAPK) pathway, Phosphoinositide 3-Kinase-Akt (PI3K-Akt) pathway,
Rho-like GTPases, Wnt-βcatenin, Notch, and Hedgehog pathways [20, 42, 53, 55].

As briefly mentioned above, TGF-β1 has a prominent role in the induction of EMT. Several
isoforms of the gf exist, including: 1) TGF-β1, which is elevated in most pathologies, and
controls cell growth, proliferation, differentiation, and apoptosis, and which regulates the
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immune system, 2) TGF-β2, which is highly expressed in epithelial sense organs and
functions mainly during embryonic development, and 3) TGF-β1, which controls cellular
adhesion and ECM formation in palate development [53, 56]. The cytokine is produced
by many cell types, including T-cells, platelets, macrophages, neutrophils, bone and soft
tissues, such as placenta, kidney, endometrium, and malignant cells, and functions via
both autocrine and paracrine signaling [57]. TGF-β1 is secreted in a latent form made up
of the mature TGF-β1 sequence, an inhibitor propeptide called the latent associated
protein (LAP), and the latent TGF-β1 binding protein (LTPB) [58]. Several mechanisms
have been discovered for the activation of mature TGF-β1. These include proteolytic
activation through various enzymes such as plasmin and MMP-2/9, Thrombospondin-1
activation, cytoskeleton-integrin-ECM mediated activation through the RGD site in LAP,
activation by reactive oxygen species, and activation by pH [58, 59].

Once activated, TGF-β1 has been shown to have opposing signaling effects depending
on the mechanical environment in which the cells are in contact. During the initial stages
of breast carcinogenic progression, TGF-β1 has been shown to exhibit a growth inhibitory
effect, causing cells to undergo an apoptotic mechanism, whereas in late stage invasive
breast cancer, TGF-β1 promotes metastasis through enhanced cell motility, invasion,
tumor stem cell maintenance, vascularization, immunosuppression, EMT and cell survival
[11, 60-62]. Later studies showed that the switch between TGF-β1 effects was regulated
by the stiffness of the surrounding microenvironment, with cells cultured on compliant
surfaces increasing TGF-β1-induced apoptosis, whereas those cultured on rigid surfaces
increased TGF-β1-induced EMT [13].
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2.3 Biomechanical Overview of EMT
The induction of EMT has also been shown to be regulated by mechanical signaling
associated with increased substrate stiffness [13, 15, 63-65] and increased contractile
force [14, 16, 20, 66]. One important area of this mechanical regulation is in tissue
organization. In physiology, it is important for epithelial tissues to coordinate mechanical
events and maintain structural integrity to protect against mechanical disturbances. When
carried out properly, these coordinated events induce local signaling, restricting EMT to
cells in a certain region fated to transition [5].

Actomyosin contractility, the fundamental regulator of cellular tension, drives tissue
organization [67]. Intracellular isomeric tension has been shown to regulate spatial
patterning of EMT in various geometric patterns. Endogenous stress is highest along
tissue edges, which correlates to reduced cell-cell adhesion [68]. In square islands,
epithelial cells have been shown to generate higher mechanical stresses along corners
and edges as compared to centers, whereas sigmoidal monolayers exhibited highest
stress in convex regions and lowest stress in concave regions [16, 68]. These areas of
highest stress correlated with spatial patterning of EMT markers upon induction with TGFβ1 [16].

On the other hand, mammary carcinoma cells confined to square patterns under
compression exhibit a leader-cell phenotype independent of actomyosin contractility.
Leader cells form along the entire square boundary in compressed cultures, whereas in
uncompressed cultures, leader cell formation occurrs only at the four corners of the
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squares. Extrusion of the cells along the periphery of the square islands enhanced their
adhesion to the underlying substrate, in turn regulating intracellular stress and migration
[69].

2.4 ECM in EMT
While many recent studies have highlighted the importance of mechanical signaling in
cellular events [20, 21], it is not entirely clear how the combination of mechanical and
soluble signals triggers this complex transdifferentiation. One possible point of integration
is the ECM, a non-cellular structural component of all tissues and organs throughout the
body. Many ECM fibrils are assembled in response to cell-applied contractile forces, and
many ECM proteins contain binding sites for gfs that allow the matrix to serve as a sink
or reservoir for presentation of soluble gfs to the cell as organized solid-phase ligands
[70-75]. Reorganization of the ECM into a favorable microenvironment has been shown
to regulate the release of cancer cells from tumor dormancy [76].

One particularly attractive target for mechanical-chemical signal integration in the ECM is
the protein fibronectin (FN). FN is a soluble protein found in the blood plasma that is
assembled by cells into insoluble elastic fibrils [77, 78]. FN expression is increased in
wound healing [79-81], embryonic development [82-84] and malignant tumors [85-89], all
of which have been associated with EMT. Stretching FN into its open conformation via
interactions between α5β1 integrins and cytoskeletal proteins exposes cryptic domains
within the protein, such as the N-terminal Type I domains associated with FN fibril
assembly and the 12-14 Type III domains, which bind upwards of 40 soluble gf, including
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TGF-β1 HGF, CTGF, many FGFs and several PDGFs, with nanomolar affinity [22, 9092]. These studies have demonstrated that bound gfs are still able to bind to their
receptors, suggesting that FN serves as a gf delivery system as opposed to a gf
sequestering mechanism.

It is known that the inactive form of TGF-β1 bound to its Latent TGF-β Binding Protein-1
(LTBP-1) integrates into the FN matrix [23-25]. Given the prominent role of TGF-β1 in
inducing both soluble FN expression [37, 39, 93] and EMT [11, 12, 17-19], and the
evidence of TGF-β1 localization to FN fibrils [23-25], we will investigate whether FN fibrils
serve as an integration point for mechanical and chemical signals by probing the role of
FN fibrils in facilitating TGF-β1-induced EMT. We believe that investigating the interplay
between FN fibrillogenesis and soluble gf signaling is essential to understanding the
mechanism by which EMT facilitates cancer progression.

2.5 EMT in Development
Organ development requires several rounds of EMT and its inverse process
Mesenchymal-Epithelial Transition (MET). During embryonic development, there are
three sequential rounds of EMT that take place: 1) primary EMT, 2) secondary EMT, and
3) tertiary EMT. Primary EMT involves mammalian implantation, gastrulation/mesoderm
formation and neural crest delamination, giving rise to germ layer formation [5, 8].
Initiation of EMT in embryogenesis commences with apical constriction, which leads to
changes in cell shape. Some notable phases of primary EMT are as follows: 1)
specification toward a mesenchymal phenotype, 2) local spatial and temporal patterning,
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3) movement during epithelial morphogenesis, 3) disruption of basal lamina, 4) cell shape
rearrangement, 5) loss of cell-cell contact, 6) ingression into deeper tissue layers, 7)
epithelial integrity maintenance, and 8) acquirement of a mesenchymal phenotype [5].
Secondary EMT involves transition from epithelial primordia into specific cell types and
structures such as blood vessels, muscle cells, neural arches, ribs, tendons, pancreas
and liver. Lastly, tertiary EMT is characterized as the development of the cardiac
cushions, which are the precursor to cardiac valves [8].

2.6 EMT in Inflammation
EMT has been highlighted in two prominent inflammatory responses, injury and fibrosis.
During wound healing, cells at the leading edge of the wound transition into a metastable
or “partial EMT” state. Keratinocytes of the cutaneous tissue, for example, will shift from
a cuboidal to a flat morphology with extended lamellipodia [94]. This allows them to
migrate, pulling trailing cells along with loose, rather than disrupted, cell-cell contacts [8].
A similar repair process occurs within the endometrium during menstruation. After luminal
shedding, the endometrial stromal cells undergo re-epithelialization through MET. When
the balance between EMT and MET is altered, it can lead to excessive scar tissue
formation and pathological conditions such as endometriosis [95]. Misregulation of EMT
leading to scar tissue formation is also seen in fibrosis of organs such as the kidney, lung,
heart, liver, and skin. Fibrosis is associated with aberrant myofibroblast differentiation,
which leads to excessive ECM protein production in the tissue microenvironment [8, 94].
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2.7 EMT in Cancer
Throughout the years, there has been debate over if and how EMT is associated with
cancer progression. Due to expression of prominent EMT markers and regulation of
genes such as Snail, Twist, Zeb and E-cadherin, several tumor types, including
pancreatic, liver, lung, bladder, renal, colorectal, cervical, skin, ovarian, breast, and
prostate, have been reported to initiate metastasis through EMT [96]. Individual
carcinoma cells and cancer stem cells with the ability to self-renew and resist
conventional therapies [97, 98] utilize the EMT regulatory circuitry to detach from the
invasive front of a primary tumor, penetrate the ECM, enter the circulation, and deposit in
remote sites to form metastatic colonies [31-33]. The general process of metastasis
involves 1) basement membrane destruction, 2) epithelial cell detachment, 3) local
invasion along ECM fibers, 4) an EMT-associated phenotypic switch within 24-72 hours
[99-101], 5) intravasation, 6) immune system avoidance and transport through the
circulation by red blood cells, 7) extravasation into distant organs, 8) formation of micro
metastases, and 9) formation of macroscopic metastases within approximately 2 weeks
[7, 32, 55, 99, 102-104]. Steps 1-5 are associated with EMT. Interestingly, studies show
that metastasis depends on cooperation between EMT cells with invasive capabilities and
Non-EMT cancer cells with the ability to form metastatic nodules at secondary sites. It
has been shown that without both cell types migrating together, cancer cells are unable
to establish metastatic colonies at distant sites [102].

EMT has also been shown to induce therapy resistance. Two studies in particular
demonstrated that cells undergoing EMT in metastatic tumors have a heightened

17

resistance to chemotherapeutics [105]. In mammary tumors, miR-200 inhibition of Zeb1
and Zeb2, transcription factors in the EMT canonical signaling pathway, blocked the
increase in resistance to chemotherapeutic drugs in lung metastases [35].
Downregulation of Snail1 and Twist1 in pancreatic ductal adenocarcinomas enhanced
survival rates of mice treated with chemotherapeutic drugs [34]. E-cadherin loss, a
hallmark of EMT, has also been shown to exacerbate radioresistance in breast cancer
cells [106].

The American Cancer Society estimates that in 2018, there will be 268,670 new cases of
invasive breast cancer diagnosed in the United States, among both men and women, and
that approximately 41,400 individuals will die of the disease during this time period. In
fact, breast cancer alone is projected to account for 29% of all new cancer cases among
women [107]. The American Cancer Society also reports survival rates among women as
99% for stage I and II, local or confined breast cancer, 85% for stage II or III, regional
tumors spreading to surrounding tissue or nearby lymph nodes, and only 27% for stage
III or IV patients, who have distant or metastasized breast cancer. Therefore, it is readily
apparent that research aimed at combating metastasis is essential for increasing breast
cancer patient survival rates.

Women with high breast density are up to five times more likely to develop breast cancer
than women with low breast density [108-111]. Several studies have shown that tissue or
ECM stiffness modulates several stages of breast cancer metastasis [112-114]. To better
combat mammary tumorigenesis, it is imperative that we fully understand the
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physiological significance of the transformed microenvironment in disease progression.
This research seeks to explore a specific component of the dynamic process of tumor
metastasis through analysis of interconnections with the ECM.
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3.1 RATIONALE
Epithelial to Mesenchymal Transition (EMT) can be described as a genetic and
phenotypic shift in epithelial cell monolayers to mesenchymal cells [2]. Epithelial cell
sheets typically serve as a protective barrier, lining cavities and organs throughout the
body. However, upon transdifferentiation, mesenchymal cells begin to fill interstitial
spaces, driving the growth and assembly of new tissues. During embryogenesis and
organ development, EMT is under strict regulation. It is also known as a key factor in
tissue remodeling and wound healing [3-5]. When misregulated, EMT has been
implicated in diseases such as cancer and organ fibrosis [7, 8]. Epithelial cells exhibit
strong cell-cell adhesions, an apicobasal polarized distribution of organelles and
cytoskeletal components, and cortical actin surrounding the cell periphery. Upon induction
of EMT, cuboidal epithelial cells in a continuous monolayer disassemble their adherens
junctions and transform into spindle-like, elongated mesenchymal cells [8]. This transition
is accompanied by a switch to a front/back polarity that allows the cells to migrate [40].
There is also a reorganization of actin into stress fibers, which may lead to increased cell
motility and invasive properties [115]. EMT has also been shown to enhance
angiogenesis

close

to

the

tumor

microenvironment

[42].

This

misregulated

transdifferentiation has been attributed to the process by which cancer stem cells detach
from their primary tumor, penetrate the extracellular matrix (ECM) and migrate through
the blood stream to form metastatic colonies in distant tissues or organs [31].

EMT can be induced via either soluble growth factors (gfs), including Transforming
Growth Factor Beta-1 (TGF-β1) [11, 12, 18], epidermal growth factor (EGF) [10, 52],
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fibroblast growth factor (FGF), hepatocyte growth factor (HGF), platelet-derived growth
factor (PDGF), Jagged, Delta-like and Wnt ligands [9, 20] &/or by mechanical signaling,
including increased substrate stiffness [13, 15, 65, 116-120] and increased contractile
force [14, 16, 20, 66].

While many recent studies have highlighted the importance of mechanical signaling in
cellular events [20, 21], it is not entirely clear how the combination of mechanical and
soluble signals triggers this complex transdifferentiation. One possible point of integration
is the ECM. Many ECM fibrils are assembled in response to cell-applied contractile force,
and many ECM proteins contain binding sites for gfs that allow the matrix to serve as
either a sink or reservoir for soluble gfs [70-72].

One particularly attractive target for mechanical-chemical signal integration is the ECM
protein fibronectin (FN). FN is a soluble protein found in the blood plasma that is
assembled by cells into insoluble elastic fibrils [77, 78]. FN expression is increased in
wound healing [80, 81], embryonic development [82, 83] and malignant tumors [85-87,
89], all of which have been associated with EMT. FN fibrils require cellular contractile
forces to assemble. These forces stretch FN dimers from a compact conformation to an
extended conformation, which exposes a cryptic binding site that facilitates fibril growth
[73, 121]. This open conformation also exposes the 12-14 Type III domains of FN, a
heparin-binding region that binds upwards of 40 soluble gfs, including TGF-β1, HGF,
CTGF, many FGFs and several PDGFs, with nM affinity [22]. These studies have
demonstrated that bound gfs are still capable of binding their receptors, suggesting that
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FN serves as a gfs delivery system as opposed to a gf sequestering mechanism. It is
known that the inactive form of TGF-β1 bound to its Latent TGF-β Binding Protein 1
(LTBP-1) integrates into the FN matrix [23, 122], and that this binding is heparin mediated
[123].

Given the prominent role of TGF-β1 in inducing EMT [11, 12, 18, 22] and the evidence of
latent TGF-β1 localization to FN fibrils [23, 24, 122], we investigated whether FN fibrils
serve as an integration point for mechanical and chemical signals by probing the role of
FN fibrils in facilitating TGF-β1-induced EMT.

24

3.2 MATERIALS AND METHODS

3.2.1 Cell Culture and Reagents
All cells were cultured in a humidified atmosphere at 37°C with 5% CO2. Human MCF10A
mammary epithelial cells were obtained from the National Cancer Institute Physical
Sciences in Oncology Bioresource Core Facility, in conjunction with American Type
Culture Collection (Manassas, VA). MDCK II cells, canine kidney cells, were a gift from
Dr. Daniel Conway (VCU Biomedical Engineering, Richmond, VA). MCF10As were
maintained under standard culture conditions in DMEM/F-12 HEPES (Life Technologies,
Carlsbad, CA), supplemented with 5% horse serum, 0.05% hydrocortisone, 0.01%
cholera toxin, 0.1% insulin, 0.02% EGF and 1% antibiotics. MDCK II cells were
maintained under standard culture conditions in DMEM (Life Technologies, Carlsbad, CA)
supplemented with 10% fetal bovine serum and 1% antibiotics. Purified recombinant
active TGF-β1 was purchased from Sigma Aldrich (St. Louis, MO). Immunofluorescence
(IF) imaging was conducted using primary antibodies: Ms anti-Hu E-cadherin (HECD-1,
Abcam, Cambridge, United Kingdom), Rb anti-Hu FN (Abcam, Cambridge, United
Kingdom), Ms anti-Hu FN (Sigma Aldrich, St. Louis, MO), Ms anti-Hu III 12-14 FN
(Thermo Scientific, Rockford, IL), Ms anti-Hu LTBP-1 (R&D Systems, Minneapolis, MN),
Rb anti-Hu Smad2 (86F7, Cell Signaling Technology, Danvers, MA), and Rb anti-Ki-67
(Santa Cruz Biotechnology, Dallas Texas). F-actin images were acquired by labeling cells
with AlexaFluor555 Phalloidin (Life Technologies, Carlsbad, CA). Western blot analysis
was conducted using primary antibodies against Twist (Abcam, Cambridge, United
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Kingdom), Vimentin (Cell Signaling Technology, Danvers, MA) and E-cadherin (HECD-1,
Abcam, Cambridge, United Kingdom).

3.2.2 Experimental Design and Immunofluorescence Imaging
For IF experiments, glass coverslips were ethanol washed and coated with 50 µg/mL
laminin (Sigma Aldrich, St. Louis MO) for 2 hours at 37 °C. MCF10A and MDCK II cells
were plated on laminin-coated 12-mm glass coverslips at densities resulting in near
confluent monolayers. Cells were grown overnight, then EGF/serum starved for 2 hours.
Incubation with appropriate inhibitors/stimulators for 1 hour was followed by treatment
with or without 2 ng/mL of TGF-β1 for an additional 48 hours. Cells were permeabilized
with 0.5% Triton in 4% paraformaldehyde for 2 minutes, then incubated in 4%
paraformaldehyde for 20 minutes. Several PBS-rinses were performed, followed by
blocking in 0.1% BSA and labeling with primary antibody for 30 minutes at 37 ºC. Cells
were then blocked again in 0.1% BSA and incubated with the appropriate secondary
antibody for 30 minutes. Images were acquired on a Zeiss AxioObserver Z1 fluorescence
microscope using ZEN2011 software.

3.2.3 Protein Quantification
MCF10As were plated on laminin-coated 25-mm glass coverslips at densities resulting in
near confluent monolayers. Cells were treated as described above. After 48 hours, cells
were lysed with l mL of RIPA Buffer (Thermo Scientific, Rockford, IL) containing 1% Halt
Protease Inhibitor (Thermo Scientific, Rockford, IL) for one minute. The protein solution
was quantified with a BCA protein assay (Thermo Scientific, Rockford, IL) and a
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NanoDrop 2000 uv-vis spectrophotometer (ThermoFisher, Rockford, IL). Standard
polyacrylamide gel electrophoresis and Western blot procedures were employed using
the BIO-RAD Mini Trans-Blot Electrophoretic Transfer Cell apparatus, Any-kD, 4-15%,
and 7.5% bis-acrylamide crosslinked TGX Stain-Free gels and polyvinylidene fluoride
(PVDF) microporous membranes. Chemiluminescent images of the PVDF membranes
were captured via the BIO-RAD ChemiDoc Touch Imaging System. Total protein
normalization was performed on post-transfer membranes and quantification of western
blotting signals was conducted with ImageLab software.

3.2.4 Expression and Purification of FUD
cDNA for the functional upstream domain (FUD) of Streptococcus pyogenes F1 adhesin
was inserted into a bacterial expression vector that contains a C-terminal polyhistidine
tag and maltose binding protein (MBP), both of which facilitate protein purification. cDNA
was obtained from Dr. Harold Erickson, Duke University Medical Center, with permission
from Dr. Deane Mosher at the University of Wisconsin. FUD expression, purification and
determination of recombinant protein concentration has been previously described [42].
FN fibril formation was inhibited by addition of 125 nM FUD in MCF10As and 300 nM FUD
in MDCK II cells.

3.2.5 Expression and Purification of FN Lacking Growth Factor Binding Domains III
11-14
FN/D11-14 cDNA was a gift from Dr. Harold Erickson (Duke University) and was
expressed in Human Embryonic Kidney 293 cells (HEK293) as previously described
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[124]. Briefly, FN/D11-14 DNA was incubated with poly-ethylimine (PEI) at a 1:2 ratio for
10 min, and transfected into Human Embryonic Kidney 293 cells in serum-free Hybridoma
media. Cells were incubated for 10 days, and conditioned media was collected from the
cell cultures. FN/D11-14 was isolated from conditioned media by flowing over a gelatin
agarose column, which binds FN via its gelatin binding domain. The column was then
washed with PBS, and FN/D11-14 was eluted with 1 M L-arginine. L-arginine was
subsequently removed by buffer exchange via PD-10 desalting columns. Expression was
confirmed by polyacrylamide gel electrophoresis on a 7.5% bis-acrylamide crosslinked
TGX Stain-Free gel.

3.2.6 Migration Assay
A two-day migration assay was conducted according to xCELLigence RTCA DP System’s
general cell migration protocol. MCF10As were EGF starved in low serum (0.5%)
overnight and then harvested in 0.05% trypsin and trypsin neutralizing solution. The CIMPlate 16 is a modified Boyden chamber that contains three essential components, a lid,
an upper chamber equipped with a microporous polyethylene terephthalate (PET)
membrane, and a gold microelectrode sensor and a lower chamber, which easily and
securely fit together. The upper chamber (containing low serum/EGF free media) and
lower chamber (containing media with normal serum/EGF levels to serve as a
chemoattractant) of the CIM-Plate 16 were equilibrated with the appropriate combination
of 2 ng/mL TGF-β1 and 125 nM FUD to avoid creating a gradient of either additive.
Approximately 0.4x105 cells were seeded in each well. The four conditions (with or without
FUD &/or TGF-β1) were carried out in quadruplicate. Cells were either stimulated or
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inhibited to travel through the membrane (average pore size 8 um) on the bottom of the
upper chamber into the well of the lower chamber by the chemoattractant and
combination of FUD/TGF-β1. Migration was monitored for 48 hours, and the cell index
was recorded by the RTCA DP Instrument. Once the cells translocated from the upper
chamber through the microporous membrane, they adhered to the microelectrode sensor
surface before migrating to the lower chamber. The microelectrode sensor generated
higher impedance values as more cells came into contact, which corresponded to higher
cell index levels. These values were sensed by the RTCA DP analyzer, which was placed
inside a tissue culture incubator along with the CIM-Plate 16.

3.2.7 Ordinal Scale Scoring of Images
To quantify the effect of fibrillogenesis on the initiation of EMT by TGF-β1, we analyzed
IF image morphology via an ordinate scale. Three independent scientists were asked to
blindly rank IF images for each experimental condition. Scores ranged from 1 to 4 and
were based on separate criteria for actin images and E-cadherin images. For actin
images, a score of 1 corresponded to cortical actin surrounding the periphery of the cell,
a score of 2 corresponded to mostly cortical actin with some stress fiber assembly
throughout the middle of the cell, a score of 3 corresponded to 50 percent cortical actin
and 50 percent randomly oriented stress fibers and a score of 4 corresponded to distinct
stress fibers oriented parallel to one another, across multiple cells, with no cortical actin.
For E-cadherin images, a score of 1 corresponded to E-cadherin within a thin line around
each cell with the formation of a uniform sheet of cells, a score of 2 corresponded to some
E-cadherin drifting towards the nucleus with junctions partially intact, a score of 3
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corresponded to a zigzag pattern around the junctions and a score of 4 corresponded to
complete disassembly with no E-cadherin surrounding the cell.

3.2.8 FN Fibril Quantification
To quantify FN fibrillogenesis, IF images of FN were analyzed via an image processing
algorithm in Matlab that creates a binary mask of each FN image and determines the total
area occupied by FN fibrils per image. These values were normalized by the total image
size.

3.2.9 LTBP-1 Colocalization Quantification
To quantify LTBP-1 colocalization with FN fibrils, IF images of LTBP-1 and FN were
analyzed via an image processing algorithm in Matlab that creates a binary mask of each
LTBP-1 image, as well as each FN image, and determines the areas in which LTBP-1
overlays FN fibrils per image.

3.2.10 Average Cell Area Quantification
To quantify the average cell area, IF images of F-actin and nuclei were analyzed via an
image processing algorithm in Matlab. Total cell area was determined through creation of
a binary mask of each F-actin image followed by calculation of the total area occupied by
F-actin per image. Cell number was determined by the total number of nuclei per image.
The algorithm then divided the total cell area by the cell number to generate the average
cell area.
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3.2.11 Nuclear Signaling Quantification
Smad2 and Ki67 were measured based on localization within the cell nucleus. IF images
of either Smad2 or Ki67 and nuclei were analyzed via an image processing algorithm in
Matlab. The intensity of the protein inside the nuclei was quantified using mean intensity
within the nuclear region, as defined by the complementary nuclei image. Cytoplasmic
intensity was determined by the mean intensity of the protein outside of the nuclear
boundaries. Nuclear colocalization is represented by the ratio of nuclear intensity to
cytoplasmic intensity.

3.2.12 Cell Density Quantification
Values for proliferation were based on correlation with the nuclei count. IF images of
nuclei were analyzed via an automated counting function in ImageJ.

3.2.13 Cell Extraction from Extracellular Matrix
MCF10As were plated on laminin-coated 12-mm glass coverslips at densities resulting in
near-confluent monolayers. Cells were treated as described in Section 4.2 with or without
2 ng/mL TGF-β1 and cultured for 48 hours. Cell extraction was performed as described
in [125]. Briefly, cells were treated with extraction buffer (0.5% (v/v) Triton-X-100, and 20
nM NH4OH in PBS) for 5 minutes, followed by gentile PBS rinsing. Samples were either
1) fixed with 1% gluteraldehyde and 1M ethanolamine for 30 minutes each, rinsed with
PBS, treated with 1mg/mL sodium borohydride to reduce autofluorescence due to
glutaraldehyde and stained for F-actin and FN as described in 4.2, or 2) cultured with new
MCF10As [126]. Cells cultured on pre-assembled ECM were EGF and serum starved 3-
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6 hours after plating and grown for an additional 24 hours, at which point they were fixed
and stained as described in 4.2.

3.2.14 Real Time Quantitative PCR Analysis
Total RNA was collected using an RNeasy kit (Qiagen). cDNA was converted using
reverse transcriptase from an iScript cDNA Synthesis Kit (Bio-rad). The cDNA was
selectively amplified by predesigned primer sets to the gene of interest (IDT). An 18s
specific primer set (IDT) was used as a normalization control. A Power SYBR reporter
(Fisher) was used for the qRT-PCR assays, which were measured using a CFX Connect
Real-time System (Bio-rad). Experiments were completed using the comparative Ct
model in triplicate, and analyzed by normalizing the values to the -/- control using
Microsoft Excel and Bio-rad CFX Manager.

3.2.15 Statistical Analysis
A One-way ANOVA followed by a 2-tailed t-test determined statistically significant
differences between groups. Statistics were analyzed via Excel and Matlab.
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3.3. RESULTS

3.3.1 FN Fibril Assembly is Increased During Epithelial to Mesenchymal Transition
As an initial investigation, we explored whether FN fibril assembly was altered in response
to EMT that was induced by either exogenous active TGF-β1 or conditioned media from
MDA-MB-231 malignant breast cancer cells (Fig. 3.1A-I), which have been shown to
express TGF-β1 [127-129]. While previous studies have demonstrated that FN mRNA
levels and protein expression are both upregulated in response to TGF-β1 [36-39], it is
not clear whether this translates into increased assembly of FN fibrils, which require
application of cellular contractile forces to soluble FN. MCF10A human breast epithelial
cells were EGF and serum starved for 2 hours, then either exposed to 2 ng/mL TGF-β1
or left untreated in EGF and serum-free conditions for 48 hours. Cells cultured in EGFfree/serum-free media maintained an epithelial phenotype, as evidenced by the
cobblestone morphology visible in actin IF images; these cells assembled no detectable
FN fibrils. When exposed to TGF-β1, cells transformed to a mesenchymal phenotype, as
depicted through the loss of cobblestone morphology and the acquisition of prominent Factin stress fibers. Under these conditions, FN fibril assembly was significantly increased.
While these results show that FN fibril assembly is induced during EMT, they do not
indicate a causal relationship. We next probed for a role for FN assembly in EMT through
inhibition of FN fibrillogenesis.

3.3.2 Inhibition of FN Fibril Assembly Inhibits Aspects of EMT, TGF-b1 Signaling,
Changes in Cell Area and Cell Density, and Cell Migration
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Figure 3.1. TGF-β1 and tumor cell-conditioned media induce FN fibril assembly in
MCF10As. (A-C) Representative IF images of MCF10As cultured in EGF/serum depleted
medium for 48 h. (D-F) MCF10As cultured in conditioned medium from MDA-MB-231
malignant breast cancer cells for 48 h. (G-I) MCF10As cultured in EGF/serum-free
medium, with the addition of 2 ng/mL TGF-β1 for 48 h. Ab staining for F-actin (red) and
FN (white). Scale bar is 20 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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To test whether FN fibrils play a functional role in facilitating EMT, we inhibited FN
assembly with a 49 amino acid peptide from the functional upstream domain of the S.
pyogenes protein Adhesin F1, which has previously been used to inhibit FN fibril
formation [130, 131]. To examine the efficacy of this peptide (referred to subsequently as
‘FUD’), we incubated TGF-β1-treated MCF10As with increasing concentrations of the
FUD inhibitor (Fig. 3.2A). The total fibril area was summed for each image and normalized
to the control case in which no FUD was administered, as described in Materials and
Methods. Data indicate that FUD treatment inhibited roughly 70% of FN fibril formation at
concentrations of 125 nM or greater (Fig. 3.2B).

MCF10As were then cultured with either FUD, TGF-β1, or the combination of the two to
determine the effects of FN fibril inhibition on EMT. Cells were EGF/serum starved for 2
hours, at which point FUD was added. TGF-β1 was then added 1 hour later to ensure
that FN fibril assembly was inhibited prior to addition of TGF-β1. Fig. 3.3A shows
representative images from MCF10As cultured +/- 125 nM FUD and +/- 2 ng/mL TGF-β1.
In the absence of TGF-β1 or FUD, cells exhibited a classic epithelial phenotype. Addition
of TGF-β1 disrupted adherens junctions, induced F-actin stress fibers and induced
assembly of FN fibrils. Cells cultured in both TGF-β1 and FUD had no significant FN fibril
formation and also maintained the key characteristics of the epithelial phenotype,
including E-cadherin containing junctions and peripheral actin. Note that under these
conditions, there were some changes in actin organization; however, these cells lacked
the prominent stress fibers observed when treated with TGF-β1 alone. Treatment with
FUD alone had no detectable effects on the epithelial phenotype. Quantification of the
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Figure 3.2. Fn fibril assembly is inhibited by the peptide FUD in TGF-β1-treated
MCF10As. (A) Representative IF images of MCF10As co-cultured with increasing
concentrations of FUD and 2 ng/mL TGF-β1 for 48 h. Ab staining for FN (white). Arrows
indicate perinuclear expression of soluble FN. FN fibril structure, as indicated by multicolor labels. (B) Quantification of average fibril area per image for each condition,
normalized to the control (0 nM FUD). N ≥ 5 for each condition. *p = 0.0138 significantly
different from control, One-way ANOVA followed by Student’s t-test. Scale bar is 10 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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total FN fibril area per image was determined for each condition as described in Materials
and Methods (Fig. 3.3B). In comparison to the positive control (treatment with TGF-β1),
the average fibril area for the negative control and the co-treated condition decreased
significantly by approximately 90% and 50% respectively. EMT marker presence was
also quantified via an ordinate scale for actin and E-cadherin images, described in the
Materials and Methods section below (Fig. 3.3C). These showed a statistically significant
change in response to TGF-β1 that was inhibited by co-treatment with FUD.

To further quantify the effects of FN fibrils on EMT, we measured protein expression levels
for several key mesenchymal markers (Fig. 3.3D-F). Expression of the intermediate
filament protein vimentin, a classic marker of EMT [22, 132], significantly increased in
response to TGF-β1; this increase was inhibited when co-treated with FUD and TGF-β1.
We observed a strong but non-significant increase in the transcription factor Twist (p =
0.17) in the presence of TGF-β1. This increase in Twist was downregulated upon cotreatment with FUD and TGF-β1. Twist is known to downregulate the expression of Ecadherin [133, 134]; as such, while we saw no significant change in E-cadherin
expression, downregulation of E-cadherin may occur at later stages of EMT. These data
suggest that inhibition of FN fibrils inhibits mesenchymal marker expression in mammary
epithelial cells.

To ensure that FN fibril inhibition blocks TGF-β1-induced EMT via the TGF-β pathway,
cells were IF-labeled with an anti-Smad2 antibody. Smad2 is part of the Smad2/3
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Figure 3.3. Inhibition of FN assembly blocks TGF-β1-induced EMT in MCF10As. (A)
IF images of MCF10As after 48 hours of treatment with TGF-β1 and/or FUD. Ab staining
for F-actin (red), E-cadherin (green), and FN (white). (B) Quantification of average fibril
area per image. N ≥ 9 for each condition. (C) Quantification of EMT markers actin and Ecadherin via ordinate scale. N ≥ 4 for each condition. (D-F) MCF10As were treated with
TGF-β1 and/or FUD for 48 hours and analyzed for EMT markers. Whole-cell lysates (1530 μg total protein) were probed by Western blotting for (D) Twist, (E) Vimentin, and (F)
E-cadherin markers. Band optical density was quantified and normalized to total lane
protein. Data is presented as percentage of negative control optical density. n.s., not
significant; N ≥ 4 for each condition. *p ≤ 0.01 significantly different from control or TGFβ1, and **p ≤ 0.1 significantly different from control, Student’s t-test. Scale bar is 50 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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complex, which is phosphorylated by the TGF-βRII receptor following ligation of TGF-β1
to the receptor [135, 136]. Upon phosphorylation, Smad2 translocates to the nucleus,
where it acts to repress E-cadherin expression and trigger EMT. MCF10As were cultured
under four conditions; EGF/serum-free media, treatment with FUD alone, TGF-β1 alone
and a co-treatment of the two, for 48 hours (Fig. 3.4A). In the control condition, Smad2 is
distributed throughout the cytoplasm; upon addition of TGF-β1, it translocates to the
nucleus. Co-treatment with both TGF-β1 and FUD inhibited the nuclear localization of
Smad2, indicating that blocking FN fibrillogenesis specifically inhibits the TGF-β signaling
pathway. FUD treatment alone had no effect on Smad2 (Fig. 3.4A). Quantification of
nuclear colocalization of Smad2 was accomplished for each condition as described in
Materials and Methods (Fig. 3.4C). After 48 hours of treatment with TGF-β1, the nuclear
intensity of the Smad2 protein was much greater than the cytoplasmic intensity. These
effects were blocked with co-treatment of FUD and TGF-β1.

TGF-β1 has been shown to induce increases in mammary epithelial cell size through
activation of mammalian target of rapamycin (mTOR) [137]. We show that after 48 hours
of treatment with TGF-β1, MCF10As exhibit larger cell area, and that co-treatment with
FUD and TGF-β1 blocks this increase in size. Quantification of the average cell area was
accomplished for each condition as described in Materials and Methods (Fig. 3.4D). In
addition, treatment with TGF-β1 decreases the cell density. This effect is blocked through
co-treatment with FUD and TGF-β1 (Fig. 3.4B). Quantification of cell density was
accomplished for each condition as described in Materials and Methods (Fig. 3.4E).
Previous studies have shown that TGF-β1 inhibits cell proliferation [138, 139]. Therefore,
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Figure 3.4. FN fibril inhibition blocks the TGF-β pathway, inhibits cell size, cell
number, and decreases migration in MCF10As. (A) Representative IF images of
Smad2 in MCF10As after 48 hours of treatment with TGF-β1 and FUD. (B) IF images of
nuclei from part A. (C) Quantification of nuclear colocalization of Smad2. N ≥ 16 for each
condition. *p < 0.01 significantly different from TGF-β1, Student’s t-test. (D) Quantification
of average cell size per condition. N ≥ 16 for each condition. *p < 0.01 significantly
different from all other conditions, Student’s t-test. (E) Quantification of cell density. N ≥
16 for each condition. *p < 0.01 significantly different from all other conditions, Student’s
t-test. (F-G) Migration kinetics of MCF10A cells by continuous monitoring of live cell
migration for approximately 48 hours. Direct comparison of FN fibril inhibitor &/or TGF-β1
effects on cell migration (F) after 24 hours, and (G) after 48 hours. Control samples served
as the baseline cell index levels for comparison with wells containing a combination of
FUD &/or TGF-β1. Cell index values from 4 wells per condition ± SD correspond to
impedance from microelectrode sensor. **p < 0.05 significantly different from all other
conditions, Student’s t-test. Scale bar is 50 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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we investigated the effect of FUD treatment on cell proliferation via Ki67 imaging.
Treatment with TGF-b1 alone showed a significant decrease in proliferation as compared
to the control (Fig. 3.5A). These effects were blocked upon co-treatment with FUD and
TGF-β1. Quantification of nuclear colocalization of Ki67 was accomplished for each
condition as described in Materials and Methods (Fig. 3.5B).

An important implication of EMT in disease states is its association with increased
migration [32]. To assess whether MCF10A migration is increased during TGF-β1induced EMT, we measured migration using an xCELLigence RTCA real-time migration
system. Cells were plated into wells within the system and migration was tracked in real
time for approximately 48 hours after TGF-β1 and/or FUD treatment. Cell migration was
determined by changes in impedance measurements of the microelectrode sensor as
cells travelled from the upper chamber, through the microporous membrane, to the lower
chamber and reported as cell index. Increases in cell index represent enhanced migratory
kinetics. Each condition was repeated in quadruplicate wells. After 24 hours, there was
very little migration exhibited by the control, whereas migration was increased by 57%
when MCF10As were exposed to TGF-β1; this increase was inhibited when cells were
co-treated with FUD and TGF-β1, indicating that blocking FN fibril growth inhibits EMTinduced migration (Fig. 3.4F). In the time frame between 24 and 48 hours, the FUD
inhibitory effect wanes, as exhibited by the increase in cell index of the TGF-β1/FUD
condition (Fig. 3.4G).
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Figure 3.5. Decreased proliferation due to TGF-β1 in MCF10As is attenuated by FN
fibril inhibition. (A) Representative IF images of Ki67 in MCF10As after 48 h of treatment
with TGF-β1 and/or FUD. Ab staining for nuclei (blue) and Ki67 (red). (B) Quantification
of nuclear colocalization of Ki67 per image for 48 hours. N ≥ 15 for each condition. *p <
0.01 significantly different from all other conditions, Student’s t-test. Scale bar is 20 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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3.3.3 EMT is Not Dependent Solely on the Presence of Soluble FN, Contractile
Forces, or FN Fibrils
Having established a prominent role for FN fibrils in TGF-β1 signaling, aspects of EMT,
and epithelial cell migration, we next investigated the mechanism that underlies this
effect. We envisioned four possible mechanisms: 1) elevated levels of soluble FN alone
drive EMT; 2) FN fibrils alter the contractile state of the cell, thus driving EMT; 3) the
presence of FN fibrils drives EMT, independently of TGF-β1; or 4) FN fibrils cluster newly
synthesized, endogenous latent TGF-β1 at the cell surface to upregulate TGF-β signaling.

Previous studies have shown that TGF-β1 induces increased expression of soluble FN
[36-39] and that soluble FN expression is increased in many malignant tumor cells [85,
87]. Assembled FN fibrils are comprised of both FN secreted from the cells (cellular FN)
and FN within the serum (plasma FN) [140]. Initially, we investigated the role of FUD on
the expression of cellular FN. MCF10As treated with TGF-β1 exhibited elevated
expression of FN compared to controls. Cells that were co-treated with FUD and TGF-β1
also exhibited elevated expression of cellular FN (Fig. 3.6A), suggesting that TGF-β1induced changes in FN expression are upstream of FN fibril-dependent signaling.

Next, we sought to determine the source of FN in fibrils assembled by MCF10As (Fig.
3.6B-D). Cells were incubated with plasma FN and TGF-β1, and the source of FN was
probed through the use of a monoclonal Ab (3E2) specific to cellular FN and a polyclonal
Ab that reacts with all FN. The concentration of exogenous soluble FN was selected
based on previously measured concentrations in the plasma of patients with malignant
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tumors [141-143]. MCF10As were EGF and serum starved and then exposed to 10 nM
soluble FN and 2 ng/mL TGF-β1 for 6, 12, 24 and 48 hours (images not shown).
Quantification of total and cellular FN fibril area per image was accomplished as
described in Materials and Methods (Fig. 3.6B). Data indicate that after 6 hours, TGF-β1
began to stimulate FN fibril assembly, which continued to increase upon prolonged
exposure to TGF-β1. Cellular FN fibril assembly area however, remained low at early time
points, increasing slightly after 24 and 48 hours. Colocalization of cellular and total FN
fibrils also remained low at early time points, with a significant increase at 24 and 48 hours
(Fig. 3.6C). These results indicate that at early time points, FN fibrils are primarily
comprised of exogenous plasma FN present in serum. However, cellular FN content
increases at later time points (24 and 48 hours). This is consistent with the expectation
that de novo cellular FN is not synthesized and secreted until 24 hours after TGF-β1
exposure.

We next tested whether soluble FN could drive EMT independently of TGF-β signaling.
Exogenous plasma FN was added to MCF10A culture medium in increasing
concentrations from 0 – 10 nM in the absence of EGF, serum, or TGF-β1. As compared
to cells treated with TGF-β1, those treated with exogenous, soluble FN neither induced
FN fibril assembly (Fig. 3.6D), nor induced EMT, as observed through E-cadherin staining
in IF images (Fig. 3.6E). This indicates that soluble FN alone is insufficient to induce EMT
in these cells.
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We next examined a role for contractile forces in the induction of FN-fibril induced EMT,
since it is well established that FN fibrils require cell-generated contractile forces to be
Figure 3.6. Increased exposure to soluble FN is insufficient to drive EMT. (A)
MCF10As were treated with TGF-β1 and/or FUD for 48 hours and whole-cell lysates (1530 μg total protein) were probed by Western blotting for expression of cellular FN. Band
optical density was quantified and normalized to total lane protein. Data is presented as
percentage of negative control optical density. Two-way ANOVA (+/- FUD, +/- TGF-β1),
N ≥ 12 for each condition. **p ≤ 0.05 TGF-β1 significantly different from all other
conditions, Student’s t-test. (B) Quantification of cellular FN fibril area and total FN fibril
area per image over time. N ≥ 12 for each condition. (C) Quantification of percentage of
overlap between cellular FN fibrils and total FN fibrils. N ≥ 12 for each condition. *p ≤ 0.01
significantly different from 6 hours or 12 hours, Student’s t-test. (D) Quantification of
percent of total image area occupied by FN fibrils for MCF10As cultured with increasing
concentrations of exogenous FN. n.s., not significant; One-way ANOVA, N ≥ 5 for each
condition. *p ≤ 0.01 significantly different from all other conditions, Student’s t-test. (E) IF
images of MCF10As cultured with increasing concentrations of soluble FN for 48 hours.
Ab staining for FN (white), and E-cadherin (green). Scale bar is 50 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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E-cadherin

assembled. MCF10As were treated with one of three force-altering compounds: 1) Rho
Kinase inhibitor Y27632, which decreases myosin phosphorylation, and thus cell
contractility; 2) blebbistatin, a myosin II inhibitor also shown to decrease cell contractility
[144-146]; or 3) Calyculin A, a phosphatase inhibitor which has previously been shown to
activate acto-myosin contractility [147]. To examine the effect of inhibiting cell contractility
on the induction of EMT, MCF10As were co-cultured with either 20 µM Y27632 and 2
ng/mL TGF-β1 or 20 µM blebbistatin and 2 ng/mL TGF-β1 for 48 hours. Results showed
that inhibition of contractile forces blocked the phenotypic changes seen with TGF-β1
treatment alone (Fig. 3.7A), and significantly lowered FN fibril assembly (Fig. 3.7B).
These results indicate that inhibition of contractile forces blocks TGF-β1-induced EMT,
which is consistent with previous data that demonstrates that TGF-β1 acts through the
Rho/ROCK pathway [148, 149]. Since FN polymerization and matrix assembly have been
shown to be mediated through the RhoA pathway [150], we investigated whether
stimulating cell contractility in a soluble FN-rich environment would be sufficient to induce
FN fibril assembly and subsequent EMT. Therefore, we cultured MCF10As with either 0.3
nM Calyculin A or co-treated with both 0.3 nM Calyculin A and 10 nM soluble FN.
Increasing contractile forces had no effect on actin organization, nor did they cause
disruption of cell-cell junctions, indicating that these cells did not undergo EMT (Fig. 3.7A).
Cells treated with both FN and Calyculin A showed a significant increase in FN fibril
assembly as compared to cells cultured in the absence of EGF/serum. However, FN fibril
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area was significantly lower in cells treated with Calyculin A and co-treated with Calyculin
A and FN as compared to cells treated with TGF-β1 alone (Fig. 3.74B). This indicates
Figure 3.7. Manipulation of contractile forces affects both assembly of FN fibrils
and EMT. (A) Representative IF images of MCF10As cultured for 48 hours in EGF/serumfree medium with (column 1) no additions, (column 2) 2 ng/mL TGF-β1, (column 3) 20 μM
Y27632 with 2 ng/mL TGF-β1, (column 4) 20 μM blebbistatin with 2 ng/mL TGF-β1,
(column 5) 0.3 nM Calyculin A and (column 6) 10 nM FN with 0.3 nM Calyculin A. Ab
staining for F-actin, (red) E-cadherin (green) and FN (white). (B) Quantification of average
fibril area per image. N ≥ 13 for each condition. *p < 0.01 significantly different from
control, **p < 0.05 significantly different from TGF-β1, Student’s t-test. Scale bar is 50
µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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that increasing contractile force alone does not induce FN assembly or EMT
independently.

Finally, we sought to determine whether the presence of FN fibrils alone was capable of
inducing EMT. This investigation was aided by a fortuitous discovery while exploring EMT
in other epithelial cell lines. MDCK II cells exhibit moderate FN fibrillogenesis even in the
absence of gf induction. Interestingly, this naturally occurring FN fibrillogenesis did not
induce EMT in these cells as exhibited through the presence of cortical actin around the
periphery of the cell (Fig. 3.8A). MDCK II cells cultured in medium containing exogenous
active TGF-β1 increase deposition of LTBP-1, which is a protein in the latent TGF-β1
complex. Given that LTBP-1 is incorporated into the ECM upon secretion from the cell,
specifically binding to FN fibrils [23, 24, 122], we investigated whether MDCK II cells
would increase secretion of LTBP-1 and integrate LTBP-1 into the FN matrix upon
stimulation from active TGF-β1. In control conditions, there was no notable LTBP-1
expression and colocalization with FN fibrils. However, when exogenous active TGF-β1
was added to the media, LTBP-1 deposition and colocalization with FN fibrils significantly
increased (Fig. 3.8B-C). Actin was also reorganized into parallel stress fibers (Fig. 3.8A).
Co-treatment with FUD and TGF-β1 blocked actin reorganization; LTBP-1 colocalization
with FN fibrils significantly decreased in comparison to treatment with TGF-β1 alone.
These data suggest that FN fibrils alone are incapable of facilitating EMT. We also show
that manipulation of contractile forces, as described in earlier experiments, had little effect
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on LTBP-1 deposition compared to samples treated with TGF-β1 alone (Fig. 3.9A-B).
Inhibition of contractile forces decreased LTBP-1 deposition and colocalization with FN
Figure 3.8. Inhibition of FN fibrillogenesis blocks TGF-β1-induced colocalization of
LTBP-1 on FN fibrils in MDCKII cells. (A) IF images of MDCKII cells after 48 hours of
treatment with TGF-β1 and FUD. Ab staining for F-actin (orange), FN (green) and LTBP1 (red). Composite displays colocalization of FN and LTBP-1 in yellow. (B) Quantification
of percentage of image occupied by FN fibrils and colocalized LTBP-1. N ≥ 9 for each
condition. (C) Quantification of percentage of overlap between LTBP-1 and FN fibrils. N
≥ 9 for each condition. *p < 0.01 significantly different from control, **p < 0.05 significantly
different from TGF-β1, Student’s t-test. Scale bar is 20 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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Figure 3.9. Manipulation of contractile forces affects LTBP-1 colocalization with FN
fibrils in MCF10As. (A) Representative IF images of MCF10As cultured for 48 h in
EGF/serum-free medium with (column 1) no additions, (column 2) 2 ng/mL TGF-β1,
(column 3) 20 μM Y27632 with 2 ng/mL TGF-β1, (column 4) 20 μM blebbistatin with 2
ng/mL TGF-β1, (column 5) 0.3 nM Calyculin A and (column 6) 10 nM FN with 0.3 nM
Calyculin A. Ab staining for F-actin (orange), FN (green) and LTBP-1 (red). Yellow
staining in composite images indicates FN fibril/LTBP-1 overlap. (B) Quantification of
average FN fibril area and colocalized protein per image. (C) Quantification of percentage
of overlap between FN fibrils and LTBP-1. N ≥ 11 for each condition. *p < 0.01 significantly
different from control, **p < 0.05 significantly different from TGF-β1, Student’s t-test. Scale
bar is 10 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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fibrils, while increasing contractile forces did not independently alter LTBP-1 deposition
or colocalization with FN fibrils (Fig. 3.9C). Therefore, we have shown that in the absence
of external growth factors, increased FN fibrillogenesis has a minimal effect on the
induction of EMT.

3.3.4 TGF-b1-Induced EMT Requires Localization of Latent TGF-b1 to FN Fibrils
Given that neither elevated levels of soluble FN alone, contractile forces alone, nor FN
fibrils alone induced EMT, we focused on the requirement of gf localization to FN fibrils
as the critical event in TGF-β1-induced EMT. To determine whether TGF-β1 localization
is essential to the induction of EMT, we incubated MCF10As with 11 μg/mL of FN
Antibody A32, a monoclonal antibody that binds to FNIII 12-14 [151], which is the region
of FN that contains the gf binding site [22, 152]. This region is also responsible for
mediating electrostatic interactions in the compact conformation of soluble FN [153]. As
such, this site is not exposed in soluble FN, but is exposed in assembled fibrils [151].
Quantification of colocalization (data not shown) reveals that the total image area
containing FN fibrils occupied by colocalized monoclonal ab is approximately 40 percent.
Cells under these conditions exhibit cortical actin as opposed to those treated with TGFβ1 alone, which exhibit stress fibers, and also show reduced transcription of the
mesenchymal markers αSMA and vimentin (Fig. 3.10A). We hypothesize that exogenous
active TGF-β1 initiates EMT by upregulating expression and secretion of FN and the TGFβ1 complex, and that localization of de novo endogenous latent TGF-β1 complex to
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assembled FN fibrils is necessary for complete EMT. To confirm this, mRNA transcription
of FN and LTBP-1 were quantified in response to TGF-β1 and/or the monoclonal FN
Figure 3.10. Blocking the LTBP-1/FN binding site inhibits TGF-β1–induced EMT in
MCF10A cells. (A) Representative IF images of MCF10A cells cultured for 48 hours with
TGF-β1 and/or monoclonal FN blocking ab. Ab staining for F-actin (orange) FN (green),
and monoclonal ab (red). Composite displays colocalization of FN and monoclonal ab in
yellow. Scale bar is 10 µm. (B) mRNA levels for FN. N = 3 for each condition. **p ≤ 0.05
significantly different from TGF-β1, Student’s t-test. (C) mRNA levels for LTBP-1. N = 3
for each condition. *p ≤ 0.01 significantly different from TGF-β1, Student’s t-test. (D)
mRNA levels for EMT markers αSMA and vimentin, were determined by means of RTqPCR. N = 3 for each condition. **p ≤ 0.05, and ***p ≤ 0.1 significantly different from all
other conditions, Student’s t-test.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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blocking antibody. Results show that both FN and LTBP-1 transcription are increased in
response to TGF-β1 (Fig. 3.10B, C). Neither of these responses is inhibited by treatment
with the monoclonal antibody, suggesting that these are upstream of FN fibril signaling.
We hypothesize that downstream signaling requires both assembly of FN fibrils and
localization of newly synthesized latent TGF-β1 complex to the fibrils. We show that
blocking the gf binding site on FN fibrils inhibits TGF-β1-induced EMT, indicating that
TGF-β1 localization to FN fibrils is necessary for EMT.

To further confirm these results, we cultured cells with either wild type recombinant FN,
with a FN deletion mutant in which the 11th through 14th Type III domains have been
deleted (FN/D11-14), or with no exogenously added FN, in the presence of TGF-β1. Since
the 11th through 14th Type III domains encompass the gf binding domains, we
hypothesized that deletion of these domains should inhibit TGF-β1 localization and EMT.

Given that TGF-β1 increases expression of FN, experiments with the deletion mutant
FN/D11-14 will not eliminate all gf binding sites in fibrils but should result in a significantly
reduced population of binding sites. Results indicated that cells cultured in the presence
of FN/D11-14 had less LTBP-1 localization to fibrils relative to either no exogenous FN or
exogenous wild type FN (Fig. 3.11A). Cells cultured in FN/D11-14 also exhibited less
stress fiber formation and more cortical actin compared to samples with either no
exogenous FN or with wild type recombinant FN. Transcription of mesenchymal markers
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Twist and vimentin were also quantified in response to co-culture with TGF-β1 and
FN/D11-14. Results show that FN/D11-14 cultured cells exhibited decreased transcription
Figure 3.11. FN lacking the growth factor binding domains III 11-14 inhibits TGFβ1–induced EMT in MCF10A cells. (A) Representative IF images of MCF10A cells
cultured for 24 hours with TGF-β1 and/or FN/D11-14. Ab staining for F-actin (orange), FN
(green), and LTBP-1 (red). Composite displays colocalization of FN and LTBP-1 in yellow.
mRNA levels for (B) EMT markers twist and vimentin, were determined by means of RTqPCR. N = 3 for each condition. *p < 0.005, and **p < 0.05 significantly different from
TGF-β1, Student’s t-test. Scale bar is 10 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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levels compared to cells treated with TGF-β1 alone, or with wild type recombinant FN and
TGF-β1 (Fig. 3.11B). Therefore, we show that exposing cells to FN fibrils lacking the gf
binding domain inhibits both colocalization with LTBP-1 and TGF-β1-induced EMT,
further indicating that the LTBP-1/latent TGF-β1 complex localization to FN fibrils is
necessary for EMT.

As additional support for this hypothesis, we cultured cells in increasing concentrations
of TGF-β1 in the presence of the FN assembly inhibitor. If FN fibrils indeed act as a
mechanism to concentrate latent TGF-β1, then increasing exogenous active TGF-β1
should begin to overcome the FN fibril dependent responses. Indeed, increasing the
soluble concentration of active TGF-β1 10-fold from the baseline value showed some
evidence of EMT, even in the presence of FUD (Fig. 3.12A-P).

3.3.5 FN Fibrils That are Pre-Assembled in the Presence of TGF-b1 are Capable of
Inducing EMT in the Absence of Exogenous Active TGF-b1
To further investigate our hypothesis that EMT requires both assembly of FN fibrils and
localization of gfs to these fibrils, we conducted a bank of experiments using preassembled ECM. MCF10As cultured on pre-assembled ECM in the presence of TGF-β1
could be induced to undergo EMT in the absence of additional TGF-β1. MCF10As were
cultured with or without TGF-β1 for 48 hours, at which point cells were extracted from the
ECM (Fig. 3.13A). New MCF10As were then grown on the pre-assembled ECM and
cultured for an additional 24 hours, in the absence of active TGF-β1. Cells cultured on
ECM that was assembled by TGF-β1-treated cells appeared to be transformed, as
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Figure 3.12. Increasing concentrations of TGF-β1 block effects of FN fibril inhibitor
and promote EMT. IF images of MCF10As after 48 h of treatment with FUD and (A-D) 2
ng/mL, (E-H) 5 ng/mL, (I-L) 10 ng/mL, and (M-P) 20 ng/mL of TGF-β1. Ab staining for Factin (red), E-cadherin (green), and FN (white). Scale bar is 20 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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Figure 3.13. MCF10As on cell-extracted ECM. (A) Representative IF images of the
resulting MCF10A matrix after treatment with or without TGF-β1 for 48 hours. (B)
Representative IF images of MCF10As cultured on pre-assembled ECM from cells
treated with or without TGF-β1 for 48 hours and cultured for an additional 24 hours. Ab
staining for F-actin (red), E-cadherin (green), and FN (white). Scale bar is 20 µm.

Figure reprinted with permission from Griggs, L. A., Hassan, N. T., Malik, R. S., Griffin, B.
P., Martinez, B. P., Elmore, L. W., Lemmon C.A. “Fibronectin Fibrils Regulate TGF-β1induced Epithelial-Mesenchymal Transition.” Matrix Biol. (2017) 60-61, 157–175.
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indicated by disrupted adherens junctions and reorganized F-actin stress fibers,
compared to those cultured on pre-formed ECM cultured in the absence of TGF-β1 (Fig.
3.13B). These results indicate that pre-assembled ECM from cells cultured with TGF-β1
have the ability to transform cells without additional gf treatment.
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3.4 Discussion
TGF-β1 has been implicated as a driver of EMT and inducer of soluble FN expression;
here we demonstrate that TGF-β1-induced EMT is associated with an increase in FN fibril
assembly, and that blocking FN assembly with a bacterial protein fragment can
significantly inhibit aspects of EMT, including adherens junction disassembly and
increased expression of mesenchymal markers. Our studies further demonstrate that
EMT cannot be induced in epithelial cells simply by increasing exogenous FN, increasing
contractile forces, or by the presence of FN fibrils. It is worth noting that isolating FN fibril
signaling and contractile force signaling is difficult; the two are symbiotic, and previous
studies from our group and from others have shown that the two have reciprocal effects
[120, 154], as such, inhibiting FN will alter forces and vice versa. However, the current
study suggests that force changes alone are not sufficient to induce EMT. Furthermore,
we demonstrate that latent TGF-β1 complex expression is upregulated and localized to
FN fibrils upon treatment with exogenous active TGF-β1, and that inhibiting this
interaction with either a FN blocking antibody or a FN deletion mutant that lacks the gf
binding domains of FN inhibits aspects of EMT, including mesenchymal marker
expression and actin reorganization.

Taken together, these data indicate that TGF-β1 induces FN fibril formation and increases
the expression of endogenous latent TGF-β1 complex, then localizes new latent TGF-β1
to FN fibrils to induce EMT (Fig. 3.14A). While this provides a novel insight into a
mechanism by which an ECM protein facilitates soluble gf signaling, there are still many
questions as to how the signaling events occur. First, the results suggest a two-staged
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Figure 3.14. Schematic of the mechanism for FN matrix mediated EMT. (A)
Exogenous TGF-β1 induces production of latent TGF-β1 and increases contractile forces,
which drive fibronectin assembly. FN fibrils localize and concentrate endogenous TGFβ1 at the cell surface, in turn upregulating EMT.
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signaling event: that is, the initial addition of exogenous active TGF-β1 must induce the
assembly of FN, but only activates EMT pathways once FN assembly has proceeded.
We hypothesize that the first stage of signaling is actin rearrangement and that this
requires low concentrations of TGF-β1 to be initiated; indeed, FUD inhibition blocks most
aspects of EMT, but appears to have the least effect on actin rearrangement, suggesting
that this may be upstream of FN fibril assembly. Once assembled, the TGF-β1 signal is
amplified, which is presumably necessary for EMT signaling. Of interest is the source of
TGF-β1 in the FN localization data; by labeling LTBP-1, we only label TGF-β1 complex
that has been secreted by the cells and not TGF-β1 that is exogenously added (this TGFβ1 is the active conformation, which is cleaved from LTBP-1). This indicates that the
addition of exogenous TGF-β1 is inducing an increased expression and/or secretion of
endogenous TGF-β1. Future studies will delve into the temporal dynamics and positive
feedback mechanisms of this system.

Also of interest is the potential mechanism of how localized gfs upregulate signaling
pathways: we have hypothesized three potential mechanisms: 1) clustered gfs have an
increased local concentration, which increases the frequency of receptor-ligand binding;
2) clustered gfs lead to increased clustering of receptors, thus upregulating the frequency
of receptor autophosphorylation; and/or 3) ECM-bound gfs are internalized and
endocytosed at a lower rate, resulting in an elevated time of signal transduction. This third
mechanism is the most intriguing to us; published models have suggested that this may
be an important signaling mechanism in VEGF [155], and we investigate this possibility
by probing signal transduction from tethered TGF-β1 substrates in Chapter 5.
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Several papers have suggested that FN alone can drive EMT [26, 156]. However, we
have shown that in breast epithelial cells, this does not occur. In previous studies, cells
were plated onto FN, as opposed to our studies, in which we plate on laminin. We have
repeated these experiments on FN-coated coverslips and observe similar effects to what
is observed on laminin coated coverslips (data not shown). There are several possible
explanations for these conflicting results, but the most plausible is that there is a
difference in the composition of gfs secreted from the cells in other studies; that is, if the
cells in question secrete elevated levels of TGF-β1 (or other FN-binding, EMT-inducing
gfs), then the mere presence of FN fibrils may be sufficient to induce EMT. Future studies
will also investigate the broad applicability of these findings to both cells from other tissues
as well as other gf signaling pathways.

The effectiveness of FUD in disrupting EMT indicates a potential therapeutic intervention
for growing solid tumors and/or fibrotic diseases. By blocking FN assembly and/or gf
localization, the gf expression of resident cells is not disrupted; instead, the mechanism
of clustering and localization at the cell surface is disrupted. This may be a strategy that
allows for global blockage of disease progression in diseases associated with EMT (such
as cancer [49, 51], cirrhosis [45], or kidney fibrosis [47], regardless of which particular gf
signaling pathway is misregulated.
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4.1 RATIONALE
Epithelial to Mesenchymal Transition (EMT) is a dynamic, morphogenetic process
characterized by a phenotypic shift in epithelial cell monolayers to motile and oftentimes
invasive mesenchymal cells [1, 2]. Since its recognition in cancer in 1990, there have
been numerous studies aimed at understanding not only intracellular signaling pathways
of EMT, but also how the surrounding mechanical environment promotes EMT-related
disease progression. Recent advances point to the fact that EMT is controlled by a
combination of soluble signals, such as growth factors (gfs) and cytokines [9-12], and
mechanical stress [13-15], which modulates the process and defines the spatial location
at which it will occur [16]. To date, there has been no clear mechanism linking the two in
epithelial transdifferentiation. We have shown that blocking fibronectin (FN) fibrillogenesis
attenuates EMT by inhibiting localization of Transforming Growth Factor-Beta 1 (TGF-b1)
to the fibril matrix. Remaining however, is the need for understanding the mechanical
aspect of FN-mediated EMT.

This chapter highlights the interplay between the mechanical environment, FN
fibrillogenesis and tissue geometry. Literature has shown that high concentrations of
TGF-b1 induce spatial patterning of mammary epithelial cells cultured on FN islands, due
primarily to high intracellular tension at island edges [16]. However, the role of matrix
mechanics in facilitating this spatial patterning remains largely uninvestigated. In this
chapter, data indicate that increasing TGF-b1 concentration causes FN fibrillogenesis to
increase from corner to edge to center, which correlates with cell phenotype
transformation and a decrease in adherens junction force.
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4.2 MATERIALS AND METHODS

4.2.1 Cell Culture and Reagents
All cells were cultured in a humidified atmosphere at 37°C with 5% CO2. Human MCF10A
mammary epithelial cells were obtained from the National Cancer Institute Physical
Sciences in Oncology Bioresource Core Facility, in conjunction with American Type
Culture Collection (Manassas, VA). MDCK II cells, canine kidney cells, were a gift from
Dr. Daniel Conway (VCU Biomedical Engineering, Richmond, VA). MCF10As were
maintained under standard culture conditions in DMEM/F-12 HEPES (Life Technologies,
Carlsbad, CA), supplemented with 5% horse serum, 0.05% hydrocortisone, 0.01%
cholera toxin, 0.1% insulin, 0.02% EGF and 1% antibiotics. MDCK II cells were
maintained under standard culture conditions in DMEM (Life Technologies, Carlsbad, CA)
supplemented with 10% fetal bovine serum and 1% antibiotics. Purified recombinant
active TGF-β1 was purchased from Sigma Aldrich (St. Louis, MO). Immunofluorescence
(IF) imaging was conducted using primary antibodies: Ms anti-Hu E-cadherin (HECD-1,
Abcam, Cambridge, United Kingdom), Rb anti-Hu FN (Abcam, Cambridge, United
Kingdom), Ms anti-Hu LTBP-1 (R&D Systems, Minneapolis, MN), Ms anti-Ms N-cadherin
(BD Biosciences, San Jose, CA). F-actin images were acquired by labeling cells with
AlexaFluor555 Phalloidin (Life Technologies, Carlsbad, CA). Nuclei images were
acquired by labeling cells with NucBlue Fixed Cell Stain ReadyProbes reagent
(Invitrogen, Carlsbad, CA).
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4.2.2. Generation of Microcontact Printed Surfaces
Uniform square islands were generated as previously described [157-159]. Briefly, a
negative mold of an array of 250 µm x 250 µm squares was fabricated through
photolithography on a silicon wafer (Fig. 4.1B, E). A replica-mold of polydimethylsiloxane
(PDMS) raised stamps was coated with laminin (LN) protein. The stamp was then placed
into contact with UV-treated, PDMS coated, glass coverslips to facilitate covalent
bonding. Coverslips were fabricated through spin coating a thin layer (>10 µm) of Sylgard
184 PDMS (1:10 curing agent to base) onto the coverslips and baking overnight at 60 ºC
(Fig. 4.1C). After stamping, coverslips were treated with fluorescently labeled BSA to label
the outer microcontact printed region so as to ensure proper stamping (Fig. 4.1D).
Coverslips were then treated with Pluronic F127 to prevent cells from adhering outside of
the LN square patterns. LN was used to coat stamps to prevent acquisition of confounding
results from FN interactions.

4.2.3 Experimental Design and Immunofluorescence Imaging
0.5 x 106 MCF10As or MDCK IIs were cultured on 250 µm x 250 µm microcontact printed
square islands coated with 100 µg/mL LN. Cells were grown overnight and then
EGF/serum starved for 2 hours, at which point the islands reached 50%-70% confluency.
Cells were incubated with TGF-β1 (0, 2, 4 ng/mL) and cultured for an additional 48 hours,
resulting in fully confluent islands. Cells were permeabilized with 0.5% Triton in 4%
paraformaldehyde for 2 minutes, then incubated in 4% paraformaldehyde for 20 minutes.
Several PBS rinses were performed, followed by blocking in 0.1% BSA and labeling with
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Figure 4.1. Microcontact printing technique utilized to explore spatial patterning of
epithelial sheets. (A) Representative IF images of MCF10A cells cultured for 48 hours
with TGF-β1. Ab staining for F-actin (red), E-cadherin (green), and FN (white). Scale bar
10 µm. (B) Microfabrication technique for generation of a silicon wafer with 250 µm x 250
µm raised squares. (C) Process for microcontact printing an array of 250 µm x 250 µm
squares onto a PDMS coated coverslip. (D) Representative IF image of fluorescently
labeled BSA (white) showing the inverse of a 250 µm x 250 µm square. Scale bar 50 µm.
(E) Design of a typical stamp consisting of an array of 100 squares.
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primary antibody for 30 minutes at 37 ºC. Cells were then blocked again in 0.1% BSA and
incubated with the appropriate secondary antibody for 30 minutes. Images were acquired
on a Zeiss AxioObserver Z1 fluorescence microscope using ZEN2011 software.

4.2.4 FN Fibril Quantification
To quantify FN fibrillogenesis, IF images of FN were analyzed via an image processing
algorithm in Matlab that creates a binary mask of each FN image and determines the total
area occupied by FN fibrils per image. These values were normalized by the total image
size.

4.2.5 Average FN Fibril Length Quantification
To quantify average FN fibril length, IF images of FN were analyzed via an image
processing algorithm in Matlab that creates a binary mask of each FN image and
determines the length of a fibril based on the shortest path along the fibril from end point
to end point.

4.2.6 LTBP-1 Colocalization Quantification
To quantify Latent TGFβ1 Binding Protein-1 (LTBP-1) colocalization with FN fibrils, IF
images of LTBP-1 and FN were analyzed via an image processing algorithm in Matlab
that creates a binary mask of each LTBP-1 image, as well as each FN image, and
determines the areas in which LTBP-1 overlays FN fibrils per image.
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4.2.7 Cell Number Quantification
Values for cell number were based on nuclei count. IF images of nuclei were analyzed
via an image processing algorithm in Matlab that counts the total number of nuclei per
image.

4.2.8 Average Cell Area Quantification
To quantify the average cell area, IF images of F-actin and nuclei were analyzed via an
image processing algorithm in Matlab. Total cell area was determined through creation of
a binary mask of each F-actin image followed by calculation of the total area occupied by
F-actin per image. Cell number was determined by the total number of nuclei per image.
The algorithm then divided the total cell area by the cell number to generate the average
cell area.

4.2.9 Spatial Patterning Analysis
To quantify spatial patterning, analysis of square data was separated into corners, edges,
and centers via an image processing algorithm in Matlab. Squares were first divided into
5x5 grids. Analyses including FN fibril quantification, average FN fibril length, LTBP-1
colocalization, and cell number were done separately in each of the binned regions.
These values were then summed across the same bin space in each image in a given
condition to create a frequency map. Corner data was defined as the average of the four
corner bins, edge data was defined as the average of the 16 outer bins, and center data
was defined as the average of the 9 inner bins.
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4.2.10 FRET Analysis
To measure cell-cell junctional force, Fluorescence Resonance Energy Transfer (FRET)based, full-length E-cadherin tension biosensors were stably transfected into MDCK II
cells. Epithelial square islands were cultured as stated in 4.2.3, and images were acquired
on a Zeiss LSM 710 laser scanning microscope using ZEN2011 software as previously
described [160]. Briefly, mTFP (donor) and mEYFP (acceptor) fluorophores were imaged
utilizing spectral unmixing at 458 nm excitation. FRET ratio was determined by obtaining
the acceptor/donor ratio and multiplying with a binary mask of the junctions. This allowed
for inspection of FRET pixels of interest within outlined cell-cell junctions. Images were
manually masked through ImageJ. Background subtraction and removal of saturated
pixels was then performed via an image processing algorithm in Python. Force estimation
was based on energy transfer between fluorophores. The closer the fluorophores, the
higher the energy transfer and subsequent FRET ratio, indicating lower tension. The
further apart the fluorophores, the lower the energy transfer, indicating higher tension.

4.2.11 Statistical Analysis
All statistics were determined through either a One or Two-way ANOVA followed by
Bonferroni’s post-hoc multiple comparisons test. Statistics were analyzed via Prism 7
software.

4.3. RESULTS
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4.3.1. TGF-b1 Induced Spatial Patterning in Epithelial Square Islands
Chapter 3 detailed the process by which TGF-β1 localizes to insoluble FN fibrils to induce
transformation in epithelial monolayers [161]. Through careful investigation of monolayer
edges, IF images show that in the presence of TGF-b1, cells assemble dense, elongated
matrix, which correlates with pronounced morphological rearrangement at monolayer
edges as compared to monolayer centers (Fig. 4.1A). To investigate the correlation
between monolayer edges and pronounced TGF-b1-induced EMT, MCF10A cells were
cultured on 250 µm x 250 µm LN coated squares for 48 hours with either 0, 2 or 4 ng/mL
TGF-b1. These square islands allowed for repeatable quantification and the ability to
distinguish between corners, edges and centers. The control, 0 ng/mL TGF-b1, exhibited
some FN fibrillogenesis, as well as LTBP-1 deposition, which was observed through IF
(Fig. 4.2A). Culturing cells with both 2 ng/mL and 4 ng/mL TGF-b1 respectively caused
an increase in percent of the total image occupied by FN fibrils and subsequent a
significant increase in LTBP-1 colocalization to FN fibrils, shown in the composite image
in yellow, as compared to 0 ng/mL TGF-β1 (Fig. 4.2B, C). Although there was some
notable LTBP-1 deposition in the control, it was significantly less colocalized with FN
fibrils than in both the 2 ng/mL and 4 ng/mL conditions.

To quantify spatial patterning, IF images were divided into 5x5 grids, and analysis was
performed separately in each binned region. Frequency maps were then generated,
showcasing the average analysis in each binned region (Fig. 4.3A). Data show that in the
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Figure 4.2. Increasing TGF-β1 concentration upregulates fibronectin production
and LTBP-1 colocalization with FN fibrils in MCF10A square islands. (A) IF images
of MCF10As after 48 hours of treatment with increasing concentrations of TGF-β1. Ab
staining for Nuclei (blue), FN (green), and LTBP-1 (red). Composite displays
colocalization of FN and LTBP-1 in yellow. Scale bar 50 µm. (B) Quantification of
percentage of image occupied by FN fibrils. N = 3 for each condition. (C) Quantification
of colocalized LTBP-1 on FN fibrils. N = 3 for each condition. *p ≤ 0.05 significantly
different from 0ng/mL TGF-β1 only. P-values based on Bonferroni’s post-hoc multiple
comparisons test following One-way ANOVA.
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Figure 4.3. Increasing TGF-β1 concentration induces spatial patterning of FN fibril
area, FN fibril length, and LTBP-1 colocalization with FN fibrils in MCF10A square
islands. (A) Representative frequency maps of total FN fibril area per grid square,
average FN fibril length per grid square and total colocalized LTBP-1 per grid square. (B)
Quantification of total FN fibril area per grid square based on TGF-β1 concentration and
square location. N = 3 for each condition. (C) Quantification of average FN fibril length
per grid square based on TGF-β1 concentration and square location. N = 3 for each
condition. (D) Quantification of total LTBP-1 colocalized area per grid square based on
TGF-β1 concentration and square location. N = 3 for each condition. n.s., not significant,
*p ≤ 0.05 significantly different from both edge and corner within given concentration, **p
≤ 0.05 significantly different from both edge and center within given concentration, ***p ≤
0.05 significantly different from only corner within given concentration, $p ≤ 0.05
significantly different from all other locations within given concentration, #p ≤ 0.05
significantly different from corresponding location in 0ng/mL TGF-β1 only. P-values based
on Bonferroni’s post-hoc multiple comparisons test following Two-way ANOVA.
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control, the total fibril area per grid square was equally distributed between the corner,
edge and center of square islands after 48 hours. In samples treated with 2 ng/mL TGFb1, there was a significant increase in total fibril area at the corners as compared to the
edges and center as well as at the edges as compared to the center. As depicted in IF
images in Fig 4.2A, treatment of 4 ng/mL TGF-b1 for 48 hours produced a significant
increase in total FN area at the corners and edges of square islands as compared to the
center square. In examination across concentrations, the significant increase in total FN
area was confined to corner regions in both 2 ng/mL and 4 ng/mL TGF-b1 as compared
to 0 ng/mL TGF-b1. There was also a significant decrease in FN area at the center in 2
ng/mL TGF-b1 as compared to the control. 4ng/mL TGF-b1 treatment however, caused
FN to begin to penetrate into the square center (Fig. 4.3B). In regards to fibril length, TGFb1 concentration had no significant effect. However, fibrils within square centers were
significantly shorter than those in both corners and edges within all TGF-b1
concentrations after 48 hours (Fig. 4.3C). LTBP-1 colocalization on FN fibrils followed the
same trend as total FN fibril area. In the control, after 48 hours, there was no significant
difference in the total colocalized LTBP-1 area based on square location. Treatment with
2 ng/mL TGF-b1 for 48 hours caused a significant increase in LTPB-1 colocalization at
the corners as compared to both the edges and center. Spatial patterning between corner
and center was retained in samples treated with 4 ng/mL TGF-b1 for 48 hours. Across
concentrations, there was a significant increase in LTBP-1 colocalization at the corners
in higher doses of TGF-b1 as compared to 0 ng/mL TGF-b1. There was also an increase
in LTBP-1 colocalization at the edge in 4 ng/mL TGF-b1 treated samples as compared to
the control (Fig. 4.3D).
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In Chapter 3 we showed that TGF-b1 treatment for 48 hours increased MCF10A cell area
and decreased cell density. We also examined if these aspects of cell morphology were
affected by spatial patterning with increasing concentrations of TGF-b1. After 48 hours
under control culture conditions, MCF10A cells densely filled out square islands,
exhibiting a cobblestone morphology. 2 ng/mL TGF-b1 treatment for 48 hours caused
cells to begin to rearrange their cortical actin into stress fibers primarily at island edges
and corners. In cells treated with 4 ng/mL TGF-b1 for 48 hours, actin stress fibers
appeared to infiltrate the entire square island as shown through IF (Fig. 4.4A).
Quantification of cell number and average cell size revealed that in comparison to the
control, cells cultured with 4 ng/mL TGF-b1 for 48 hours had a significant decrease in cell
number and increase in cell size (Fig 4.4B, C). Frequency maps of binned regions showed
that cell number was highest in the control as compared to treatments with TGF-b1, but
that all conditions exhibited spatial patterning (Fig. 4.5A). Cells cultured under control
conditions for 48 hours exhibited significantly different cell numbers in the corner as
compared to the center, with the center having the highest number of cells, followed by
the edges and then the corners. Treatment with both 2 ng/mL and 4 ng/mL of TGF-b1 for
48 hours decreased the number of cells along the edges, creating a significantly lower
number of cells at both corners and edges as compared to centers within their respective
concentrations. TGF-b1 treatments also exhibited significantly lower numbers of cells at
the corners as compared to the control (Fig. 4.5B).

4.3.2 Adherens Junctions in Spatially Patterned Epithelial Square Islands
TGF-b1-induced spatial patterning was also exhibited in cell-cell junctions. MCF10As
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Figure 4.4. Increasing TGF-β1 concentration regulates cell phenotype in MCF10A
square islands. (A) IF images of MCF10As after 48 hours of treatment with increasing
concentrations of TGF-β1. Ab staining for Nuclei (blue), and F-actin (red). Scale bar 50
µm. (B) Quantification cell number. N = 3 for each condition. (C) Quantification of average
cell area. N = 3 for each condition. *p ≤ 0.05 significantly different from 0ng/mL TGF-β1
only. P-values based on Bonferroni’s post-hoc multiple comparisons test following Twoway ANOVA.
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4

Figure 4.5. Increasing TGF-β1 concentrations induce spatially localized changes in
cell number in MCF10A square islands. (A) Representative frequency maps of cell
number per grid square. (B) Quantification of cell number per grid square based on TGFβ1 concentration and square location. N = 3 for each condition. *p ≤ 0.05 significantly
different from both edge and corner within given concentration, ***p ≤ 0.05 significantly
different from only corner within given concentration, #p ≤ 0.05 significantly different from
corresponding location in 0ng/mL TGF-β1 only. P-values based on Bonferroni’s post-hoc
multiple comparisons test following Two-way ANOVA.
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cultured in control conditions for 48 hours retained a cobblestone morphology with Ecadherin present within cell-cell junctions. IF images showed that as TGF-b1
concentration increased, E-cadherin junctions began to disassemble, largely at the
periphery of square islands with 2 ng/mL TGF-b1 and into the center with 4 ng/mL TGFb1 (Fig 4.6A). Comparatively, N-cadherin did not appear in control samples, and began
to accumulate in cell-cell junctions at the corners of the squares treated with 2 ng/mL
TGF-b1 and within junctions surrounding the periphery of square islands treated with 4
ng/mL TGF-b1 (Fig 4.6B).

This cadherin shift along the corners and edges of square islands correlated with a
decrease in force within cell-cell junctions at corresponding locations. To understand
force dynamics within adherens junctions, Fluorescence Resonance Energy Transfer
(FRET)-based force biosensors were transfected into MDCK II cells. After 48 hours of
treatment with 0, 2 or 4 ng/mL TGF-b1, MDCK IIs cultured on square islands were
analyzed through live-cell imaging. The FRET ratio between acceptor and donor
fluorophores was recorded to determine the mechanical effect of TGF-b1 concentration
on MDCK II cell-cell junctions (Fig. 4.7A). FRET intensity is an estimate of force within
cell-cell junctions. When fluorophores are close in proximity, there is a high energy
transfer, corresponding to a high mean FRET ration and a low force. An increase in
tension leads to a larger distance between fluorophores and a lower energy transfer. This
corresponds to a low mean FRET ratio and high force. Frequency maps of the mean
FRET intensity showed higher values within corners and edges as compared to centers
with increasing concentrations of TGF-b1 (Fig. 4.7B). Quantification of mean FRET per
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Figure 4.6. Increasing TGF-β1 concentrations disrupt adherens junctions in
MCF10A square islands. (A) Representative IF images of MCF10A cells cultured for 48
hours with increasing concentrations of TGF-β1. Ab staining for Nuclei (blue), and Ecadherin (green). Scale bar 50 µm. (B) Representative IF images of MCF10A cells
cultured for 48 hours with increasing concentrations of TGF-β1. Ab staining for Nuclei
(blue), and N-cadherin (white). Scale bar 50 µm.
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Figure 4.7. FRET within adherens junctions decreases with increasing TGF-β1
concentration in MDCK II square islands. (A) Representative intensity images of
mEYFP (acceptor) fluorophores and FRET ratios in MDCK II cells cultured for 48 hours
with increasing concentrations of TGF-β1. Scale bar is 50 µm. (B) Representative
frequency maps of mean FRET per grid square. (C) Quantification of mean FRET per
grid square based on TGF-β1 concentration and square location. N = 2 for each condition.
n.s., not significant, ***p ≤ 0.05 significantly different from only corner within given
concentration, #p ≤ 0.05 significantly different from corresponding location in 0ng/mL
TGF-β1 only. P-values based on Bonferroni’s post-hoc multiple comparisons test
following Two-way ANOVA.
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grid square showed that there was no significance between locations in the control,
0ng/mL TGF-b1. However, treatment of MDCK IIs with 2 ng/mL and 4 ng/mL TGF-b1 for
48 hours revealed higher FRET values in all locations as compared to the control.
Treatment with 4 ng/mL TGF-b1 for 48 hours showed a significant decrease in mean
FRET in the center as compared to the control (Fig 4.7C).
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4.4 DISCUSSION

It has been established that primary embryonic epithelium undergo highly coordinated
spatial and temporal regulation of EMT due to the need for maintenance of epithelial
integrity [5]. Previous work demonstrated that the location for which EMT occurs is based
on gradients of mechanical stress [16]. It is known that TGF-b1 stimulates an increase in
vimentin and a-smooth muscle actin and reduces cytokeratin in corners and edges of
square epithelial sheets due to patterns of intercellular tension. However, much is left to
be understood about spatial patterning in the context of the ECM and downstream
morphological events.

In this chapter, we characterized TGF-b1-induced spatial patterning of FN matrix, LTBP1 colocalization with FN fibrils, cell density, cell size, and adherens junctional force. We
showed that with increasing TGF-b1 concentration, FN fibril area was preferentially
concentrated at corners and edges of square epithelial islands. The fibrils in square
corners were in fact longer than those in square centers. Epithelial cells most likely
sensed higher mechanical forces along the edges and corners of square islands, leading
to increased fibrillogenesis through force transmission from acto-myosin contractility.
LTBP-1 colocalization with FN fibrils was also spatially concentrated at corners and edges
in epithelial islands with stimulation from TGF-b1. This increase in LTBP-1 colocalization
area may be attributed to larger fibrils within corresponding locations. Larger FN fibrils
would expose a higher number of gf binding sites, cryptic within the soluble FN
conformation, which would in turn allow for a higher potential for LTBP-1 colocalization.
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We also showed that FN fibril spatial patterning correlated with spatially patterned
changes in cell phenotype. Although cell number was spatially patterned in both control
and TGF-b1 treated conditions, there was a significant decrease at the corners in the
TGF-b1 samples. This may be attributed to more FN attachment sites, leading to greater
potential for cells to spread and encompass a greater area at corner regions. Actin
organization along the periphery of cells was retained in the center of square islands but
was reorganized into elongated stress fibers at corners and edges upon stimulation with
TGF-b1. Although TGF-b1 induced spatial patterning in both concentrations, it appears
that FN assembly began to penetrate into the center square region with 4 ng/mL TGF-b1.
Actin stress fibers were also observed in the center square region with 4 ng/mL TGF-b1.
Several factors may have contributed to this decrease in spatial patterning, the most
logical being exposure to high TGF-b1 concentrations for an extended period of time.
Therefore, culture time and TGF-b1 concentration are critical factors that should be
modulated to further parse out spatial patterning dynamics.

In addition, we showed that cell-cell junctional disassembly correlates with a higher FRET
ratio. FRET efficiency is known to decrease under tension [162]. When the mTFP (donor)
and mEYFP (acceptor) fluorophores are close together, there is a higher energy transfer
from donor to acceptor. Inversely, the further apart the fluorophores are, the less energy
the donor is able to transfer to the acceptor. We have shown that mammary epithelial
cells grown under standard culture conditions for 48 hours exhibit a lower FRET ratio
throughout square islands as compared to cells cultured with TGF-b1, which is in
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agreement with previous work from Dr. Daniel Conway’s group at Virginia Commonwealth
University. Data also shows that FRET ratios are highest in the corners as compared to
the center in cells cultured with 4 ng/mL TGF-b1 for 48 hours. We believe that under
standard culture conditions, there is a basal level of tension needed to keep cell-cell
junctions together, therefore producing a lower mean FRET ratio. Disassembly of cell-cell
junctions, primarily at corners and edges of square islands, may lead to a decrease in
tension due to a lack of stability from E-cadherin molecules. This could create slack in the
elastic linker between fluorophores, potentially decreasing the distance between
fluorophores relative to that seen in intact junctions, ultimately leading to higher FRET
ratios.

Taken together, these data indicate that TGF-b1 not only spatially patterns EMT markers
but that it also induces patterning of ECM components, cell morphology, and junctional
forces. The correlation between FN fibrillogenesis, cell morphology and adherens junction
force in TGF-b1-induced spatial patterning may provide insight into pathology, physiology
and tissue repair, by understanding how gf signaling leads to coordinated mechanical
transitions. In particular, this coordination may explain why EMT is more likely to occur at
the leading edge of damaged epithelium or at the boundaries of growing tumors.
Therefore, these studies enhance our knowledge of elements associated with EMTpermissive regions within epithelial sheets.
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5.1. RATIONALE

Results from Chapter 4 highlighted a strong correlation between fibronectin (FN) matrix
assembly, Latent TGF-b1 Binding Protein-1 (LTBP-1) colocalization and a downstream
phenotypic shift, primarily at the edges and corners of epithelial square islands. Although
these data shed light on new aspects of Transforming Growth Factor Beta1 (TGF-b1)induced spatial patterning, several questions remain; 1) are FN fibrils required to mediate
TGF-b1-induced spatial patterning, 2) would spatial patterning of the downstream
morphological transformations associated with TGF-b1 concentration be affected by
inhibition of the FN matrix, and 3) is tethering of TGF-b1 to the FN matrix responsible for
spatial patterning?

Recent studies have shown that the ECM has a significant effect on cellular
communication. ECM stiffness in particular has been shown to control intercellular stress,
in turn regulating processes such as organ branching [163]. In addition, geometric cues
provided by the ECM have been shown to guide cellular protrusions, resulting in
regulation of cell shape and migration [164]. FN tracks specifically have been shown to
guide cell spreading and directionality during migration [165].

In the current chapter, we introduce a novel mechanism by which biochemical signaling
integrates into the FN matrix to induce spatial patterning of epithelial sheets. FN’s
influence was probed through two separate fashions: 1) through inhibition of FN fibril
assembly, and 2) through tethering TGF-β1 to the substrate surface, in turn bypassing
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the need for growth factor (gf) localization to the FN matrix. Results show that FN
fibrillogenesis has a profound effect on TGF-β1-induced spatial patterning of phenotypic
transformation. Data indicate that inhibition of FN fibrillogenesis and/or interference with
FN/TGF-β1 localization is sufficient to block TGF-β1-induced spatial patterning.
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5.2. MATERIALS AND METHODS

5.2.1 Cell Culture and Reagents
All cells were cultured in a humidified atmosphere at 37°C with 5% CO2. Human MCF10A
mammary epithelial cells were obtained from the National Cancer Institute Physical
Sciences in Oncology Bioresource Core Facility, in conjunction with American Type
Culture Collection (Manassas, VA). MDCK II cells, canine kidney cells, were a gift from
Dr. Daniel Conway (VCU Biomedical Engineering, Richmond, VA). MCF10As were
maintained under standard culture conditions in DMEM/F-12 HEPES (Life Technologies,
Carlsbad, CA), supplemented with 5% horse serum, 0.05% hydrocortisone, 0.01%
cholera toxin, 0.1% insulin, 0.02% EGF and 1% antibiotics. MDCK II cells were
maintained under standard culture conditions in DMEM (Life Technologies, Carlsbad, CA)
supplemented with 10% fetal bovine serum and 1% antibiotics. Purified recombinant
active TGF-β1 was purchased from Sigma Aldrich (St. Louis, MO). Immunofluorescence
(IF) imaging was conducted using primary antibodies: Ms anti-Hu E-cadherin (HECD-1,
Abcam, Cambridge, United Kingdom), Rb anti-Hu FN (Abcam, Cambridge, United
Kingdom), Ms anti-Hu LTBP-1 (R&D Systems, Minneapolis, MN), Ms anti-Ms N-cadherin
(BD Biosciences, San Jose, CA). F-actin images were acquired by labeling cells with
AlexaFluor555 Phalloidin (Life Technologies, Carlsbad, CA). Nuclei images were
acquired by labeling cells with NucBlue Fixed Cell Stain ReadyProbes reagent
(Invitrogen, Carlsbad, CA).
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5.2.2. Generation of Microcontact Printed Surfaces
Uniform square islands were generated as previously described [157-159]. Briefly, a
negative mold of an array of 250 µm x 250 µm squares was fabricated through
photolithography on a silicon wafer (Fig. 4.1B, E). A replica-mold of polydimethylsiloxane
(PDMS) raised stamps was coated with laminin (LN) protein. The stamp was then placed
into contact with UV-treated, PDMS coated, glass coverslips to facilitate covalent
bonding. Coverslips were fabricated through spin coating a thin layer (>10 µm) of Sylgard
184 PDMS (1:10 curing agent to base) onto the coverslips and baking overnight at 60 ºC
(Fig. 4.1C). After stamping, coverslips were treated with fluorescently labeled BSA to label
the outer microcontact printed region so as to ensure proper stamping (Fig. 4.1D).
Coverslips were then treated with Pluronic F127 to prevent cells from adhering outside of
the LN square patterns. LN was used to coat stamps to prevent acquisition of confounding
results from FN interactions.

5.2.3 Expression and Purification of FUD
cDNA for the functional upstream domain (FUD) of Streptococcus pyogenes F1 adhesin
was inserted into a bacterial expression vector that contains a C-terminal polyhistidine
tag and maltose binding protein (MBP), both of which facilitate protein purification. cDNA
was obtained from Dr. Harold Erickson, Duke University Medical Center, with permission
from Dr. Deane Mosher at the University of Wisconsin. FUD expression, purification and
determination of recombinant protein concentration has been previously described [42].
FN fibril formation was inhibited by addition of 125 nM FUD in MCF10As and 300 nM FUD
in MDCK II cells.
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5.2.4 Experimental Design and Immunofluorescence Imaging
0.5 x 106 MCF10As or MDCK IIs were cultured on 250 µm x 250 µm microcontact printed
square islands coated with laminin. Cells were grown overnight and then EGF/serum
starved, at which point the islands were reached 50%-70% confluency. In experiments
with FN fibril inhibition, 125 nM FUD was introduced into culture two hours after
EGF/serum starvation and 24 hours after incubation with TGF-β1. After 1 hour, cells were
incubated with TGF-β1 (0, 2, 4 ng/mL) and cultured for an additional 48 hours, resulting
in fully confluent islands. In tethering experiments, cells were cultured on TGF-β1/LN
coated islands for 48 hours. Medium was replaced 6 hours after seeding, and cells were
incubated with 125 nM FUD. After growth overnight, cells were EGF/serum starved and
incubated again with 125 nM FUD. 48 hours after initial seeding, cells were permeabilized
with 0.5% Triton in 4% paraformaldehyde for 2 minutes, then incubated in 4%
paraformaldehyde for 20 minutes. Several PBS-rinses were performed, followed by
blocking in 0.1% BSA and labeling with primary antibody for 30 minutes at 37 ºC. Cells
were then blocked again in 0.1% BSA and incubated with the appropriate secondary
antibody for 30 minutes. Images were acquired on a Zeiss AxioObserver Z1 fluorescence
microscope using ZEN2011 software.

5.2.5 FN Fibril Quantification
To quantify FN fibrillogenesis, IF images of FN were analyzed via an image processing
algorithm in Matlab that creates a binary mask of each FN image and determines the total
area occupied by FN fibrils per image. These values were normalized by the total image
size.
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5.2.6 Average FN Fibril Length Quantification
To quantify average FN fibril length, IF images of FN were analyzed via an image
processing algorithm in Matlab that creates a binary mask of each FN image and
determines the length of a fibril based on the shortest path along the fibril from end point
to end point.

5.2.7 LTBP-1 Colocalization Quantification
To quantify LTBP-1 colocalization with FN fibrils, IF images of LTBP-1 and FN were
analyzed via an image processing algorithm in Matlab that creates a binary mask of each
LTBP-1 image, as well as each FN image, and determines the areas in which LTBP-1
overlays FN fibrils per image.

5.2.8 Cell Number Quantification
Values for cell number were based on nuclei count. IF images of nuclei were analyzed
via an image processing algorithm in Matlab that counts the total number of nuclei per
image.

5.2.9 Average Cell Area Quantification
To quantify the average cell area, IF images of F-actin and nuclei were analyzed via an
image processing algorithm in Matlab. Total cell area was determined through creation of
a binary mask of each F-actin image followed by calculation of the total area occupied by
F-actin per image. Cell number was determined by the total number of nuclei per image.
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The algorithm then divided the total cell area by the cell number to generate the average
cell area.

5.2.10 Spatial Patterning Analysis
To quantify spatial patterning, analysis of square data was separated into corners, edges,
and centers via an image processing algorithm in Matlab. Squares were first divided into
5x5 grids. Analyses including FN fibril quantification, average FN fibril length, LTBP-1
colocalization, and cell number were done separately in each of the binned regions.
These values were then summed across the same bin space in each image in a given
condition to create a frequency map. Corner data was defined as the average of the four
corner bins, edge data was defined as the average of the 16 outer bins, and center data
was defined as the average of the 9 inner bins.

5.2.11 Statistical Analysis
All statistics were determined through either a One or Two-way ANOVA followed by
Bonferroni’s post-hoc multiple comparisons test. Statistics were analyzed via Prism 7
software.
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5.3. RESULTS

5.3.1. Inhibition of FN Fibrillogenesis Alters Spatial Patterning in Epithelial Square
Islands
In Chapter 4, we established that with increasing TGF-β1 concentration, there was a
pronounced spatial patterning of both FN fibrils and LTBP-1 colocalization, as well as
patterned morphological transformation and cell-cell junction force dynamics. We next
sought to determine whether these spatial patterning effects were caused by TGF-β1
location to FN fibrils. IF images show that co-culturing MCF10A cells for 48 hours with
our FN fibril inhibitor, FUD, and either 0, 2, or 4 ng/mL TGF-β1 in square islands produced
FN assembly in the corners and edges with co-localized LTBP-1, as depicted in the
composite images in yellow (Fig. 5.1A). Quantification of the percent of the total image
occupied by FN fibrils revealed that cells co-cultured with FUD and TGF-β1 assembled
less FN compared to the positive control, 4 ng/mL TGF-β1, although some fibrils were
retained even in the presence of the inhibitor (Fig. 5.1B). It is important to note that the
fibrils that were able to assemble in the presence of FUD were also able to colocalize with
LTBP-1, with no significant difference from LTBP-1 colocalization within the positive
control (Fig. 5.1C).

Quantification of FN and LTBP-1 dynamics, based on location, was performed by dividing
IF images into 5x5 grids and performing analysis separately in each binned region.
Frequency maps were then generated showcasing the average analysis in each binned
region (Fig. 5.2A). Data show that no spatial patterning existed in MCF10As co-treated
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Figure 5.1. Inhibition of FN fibrillogenesis decreases overall FN assembly but does
not affect LTBP-1 colocalization with FN fibrils in MCF10A square islands with
increasing TGF-β1 concentration. (A) IF images of MCF10As after 48 hours of
treatment with FUD and increasing concentrations of TGF-β1. Ab staining for Nuclei
(blue), FN (green), and LTBP-1 (red). Composite displays colocalization of FN and LTBP1 in yellow. Scale bar 50 µm. (B) Quantification of percentage of image occupied by FN
fibrils. N = 2 for each condition. (C) Quantification of colocalized LTBP-1 on FN fibrils. N
= 3 for each condition. *p ≤ 0.05 significantly different from positive control (4ng/mL TGFβ1, no FUD) only, **p ≤ 0.05 significantly different from all other conditions. P-values
based on Bonferroni’s post-hoc multiple comparisons test following One-way ANOVA.
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Figure 5.2. Inhibition of FN fibrillogenesis reduces effects of spatial patterning of
FN fibril area, FN fibril length, and LTBP-1 colocalization with FN fibrils in MCF10A
square islands with increasing concentrations of TGF-β1. (A) Representative
frequency maps of total FN fibril area per grid square, average FN fibril length per grid
square and total colocalized LTBP-1 per grid square. (B) Quantification of total FN fibril
area per grid square based on TGF-β1 concentration and square location. N = 3 for each
condition. (C) Quantification of average FN fibril length per grid square based on TGF-β1
concentration and square location. N = 3 for each condition. (D) Quantification of total
LTBP-1 colocalized area per grid square based on TGF-β1 concentration and square
location. N = 3 for each condition. n.s., not significant, *p ≤ 0.05 significantly different from
both edge and corner within given concentration, **p ≤ 0.05 significantly different from
both edge and center within given concentration, ***p ≤ 0.05 significantly different from
only corner within given concentration, $p ≤ 0.05 significantly different from all other
locations within given concentration, #p ≤ 0.05 significantly different from corresponding
location in 0ng/mL TGF-β1 only, ##p ≤ 0.05 significantly different from corresponding
location in 2ng/mL TGF-β1 only, ###p ≤ 0.05 significantly different from corresponding
location in 4ng/mL TGF-β1 only. P-values based on Bonferroni’s post-hoc multiple
comparisons test following Two-way ANOVA.
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with FUD and 0 ng/mL TGF-β1. There was a significant increase in FN assembly in the
corners in samples co-treated with FUD and 2 ng/mL TGF-β1, as well as a significant
increase in FN assembly in corners and edges in samples co-treated with FUD and 4
ng/mL TGF-β1. However, when comparing FN fibrillogenesis between 0 and 2 ng/mL
TGF-β1, there was no significant difference between any of the locations. Between 0 and
4ng/mL TGF-β1, the only significant increase in FN assembly was at the corners. When
comparing FUD-treated samples to the positive control, data show significantly lower
values in all locations in 0 and 2 ng/mL TGF-β1 and significantly lower values at the edges
and centers of square islands in 4 ng/mL TGF-β1 (Fig. 5.2B). In each concentration, with
the addition of FUD, FN fibril length was significantly higher at both corners and edges of
square islands as compared to the center, which is consistent with data discussed in
Chapter 4 sans the addition of FUD. All FUD/TGF-β1 co-treatments exhibited significantly
shorter FN fibrils in all locations as compared to the positive control, which retained long
fibrils irrespective of location (Fig. 5.2C). Total colocalized LTBP-1 area remained low and
non-spatially patterned in conditions co-cultured with 0 or 2 ng/mL TGF-β1 and FUD. With
4 ng/mL TGF-β1, spatial patterning developed between corners and the center. As with
FN fibril length, all FUD/TGF-β1 co-treatments exhibited significantly less LTBP-1
colocalization in all locations as compared to the positive control, which retained high
levels of colocalization irrespective of location (Fig. 5.2D).

Introducing FUD into culture with TGF-β1 for 48 hours caused variance in both cell density
and cell area. IF images show a cobblestone morphology in MCF10As treated with FUD
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alone. MCF10As co-treated with FUD and TGF-β1 formed actin stress fibers along the
square periphery, which became more pronounced with higher TGF-β1 concentration
(Fig 5.3A). Quantification of cell number and average cell area for the entire square island
revealed no statistical difference between FUD-treated samples and the positive control,
4 ng/mL TGF-β1 alone (Fig. 5.3A, B). Frequency maps of binned regions show cell
number in MCF10As co-treated with FUD and TGF-β1 aligned with data discussed in
Chapter 4 of MCF10As treated with TGF-β1 alone. Centers remained most densely
populated in all concentrations regardless of FUD treatment (Fig. 5.4A). There was a
significant difference between both edges and corners with centers in all FUD/TGF-β1
co-treated MCF10As, as well as in the positive control. No statistical difference in cell
number was noted between any of the square regions between different concentrations.

FN fibril inhibition on the other hand did have a notable effect on cell-cell junctions. FUD
treatment caused E-cadherin within junctions to remain intact regardless of TGF-β1
concentration, whereas in the positive control, junction disassembly was seen throughout
the entire square island, with more pronounced disassembly at corners and along edges
(Fig. 5.5A). FN fibrillogenesis inhibition also blocked N-cadherin from integrating into cellcell junctions. Only in the positive control was the presence of N-cadherin within adherens
junctions of cells surrounding the periphery of square islands detected. Cells treated with
4 ng/mL TGF-β1 did have a slight cadherin switch, restricted however, to square island
corners.
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Figure 5.3 Inhibiting FN assembly alters cell phenotype in MCF10A square islands
with increasing concentrations of TGF-β1. (A) IF images of MCF10As after 48 hours
of treatment with FUD and increasing concentrations of TGF-β1. Ab staining for Nuclei
(blue), and F-actin (red). Scale bar 50 µm. (B) Quantification cell number. N = 3 for each
condition. (C) Quantification of average cell area. N = 3 for each condition.
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Figure 5.4. Inhibition of FN assembly has no effect on spatial patterning of cell
number in MCF10A square islands with increasing concentrations of TGF-β1. (A)
Representative frequency maps of cell number per grid square. (B) Quantification of cell
number per grid square based on TGF-β1 concentration and square location. N = 3 for
each condition. *p ≤ 0.05 significantly different from both edge and corner within given
concentration, $p ≤ 0.05 significantly different from all other locations within given
concentration. P-values based on Bonferroni’s post-hoc multiple comparisons test
following Two-way ANOVA.
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Figure 5.5. FN fibril inhibition blocks cadherin switch in MCF10A square islands
with increasing concentrations of TGF-β1. (A) Representative IF images of MCF10A
cells cultured for 48 hours with increasing concentrations of TGF-β1. Ab staining for
Nuclei (blue), and E-cadherin (green). Scale bar 50 µm. (B) Representative IF images of
MCF10A cells cultured for 48 hours with increasing concentrations of TGF-β1. Ab staining
for Nuclei (blue), and N-cadherin (white). Scale bar 50 µm.
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5.3.2. Tethering TGF-β1 to Square Islands Alters Spatial Patterning of Epithelial
Square Islands
To analyze whether local tethering of gfs to FN matrix had a role in spatially patterned
signal transduction, we cultured MCF10As on square islands with varying TGF-β1/LN
surface concentrations. The maximum surface concentration within the range was set
based on the concentration of FN necessary to fully cover an entire surface,
approximately 364 ng/cm2 [166]. The minimum surface concentration, 0.4 ng/cm2, was
calculated using the following equation:

+,- ∙.

𝐶"#$ = 2 ∙ 𝐶) *

(5.1)

/

where Cads (µg/cm2) is how much protein is adsorbed on the surface, Co (µg/cm3) is the
protein concentration in bulk solution, Dij (cm2/s) is the protein’s diffusion coefficient and t
(s) is time. Co was set to the typical concentration of soluble TGF-β1 utilized in previous
48-hour experiments, 2 ng/mL, and Dij, 2.13 x 10-7 cm2/s, was determined from values
seen previously in literature [167]. The range was scaled between 0 and 500 ng/cm2 and
surface coverage percentages were estimated as shown in Table 5.1. We then
rearranged equation 5.1 to solve for TGF-β1 concentration in bulk solution:
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(5.2)

Table 5.1 Concentration values for surface tethered TGF-β1. The range of TGF-β1
protein adsorption as reflected by percent of surface covered, surface concentration, and
concentration in bulk solution.
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Approximate Surface
Coverage of TGF-β1 (%)

Surface Concentration of
TGF-β1 (ng/cm2)

Concentration of TGF-β1
in bulk solution for 48
hours (ng/mL)

0

0

0

0.1

0.5

2.3

1

5

23

10

50

230

100

500

2,300

Table 5.1
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These values were utilized to determine the volume of TGF-β1 necessary for adsorption
onto microfabricated stamps for 2 hours. Table 5.1 displays the concentration of TGF-β1
in bulk solution for 48 hours as a reference for comparison to standard 48-hour
experiments with soluble TGF-β1. After incubation with TGF-β1 for 2 hours, stamps were
rinsed and then incubated with 100 ng/mL LN to facilitate cell attachment. The TGF-β1/LN
combination was then covalently bonded to PDMS-coated coverslips and cells were
cultured for 48 hours.

IF images of MCF10As show that culturing cells for 48 hours on tethered surfaces
stimulated FN fibrillogenesis, actin reorganization and adherens junction disassembly.
Cortical actin surrounded the cell periphery and E-cadherin was present within cell-cell
junctions up to and including surface concentrations of 5 ng/cm2 TGF-β1. 50 ng/cm2 TGFβ1 surface concentration enabled cells to reorganize actin into stress fibers and
disassemble adherens junctions along edges and corners of square islands. Cells
cultured on square islands with the highest surface concentration, 500 ng/cm2 TGF-β1,
exhibited actin stress fibers and very minimal adherens junctions throughout the entire
square (Fig. 5.6A). Quantification of percentage of total image occupied by FN fibrils
revealed minimal FN fibril fibrillogenesis until a TGF-β1 surface concentration of 50
ng/cm2 (Fig. 5.6B). There was a slight decrease in cell number with increasing surface
concentration (Fig. 5.6C). Inversely, there was a gradual increase in cell area with
increasing surface concentration (Fig. 5.6D).
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Figure 5.6. Microcontact printing TGF-β1 increases FN assembly, decreases cell
number, and increases cell area in MCF10A square islands with increasing surface
density concentrations. (A) IF images of MCF10As cultured for 48 hours on square
islands with increasing TGF-β1 surface density concentrations. Ab staining for Nuclei
(blue), FN (white), F-actin (red), and E-cadherin (green). Scale bar 50 µm. (B)
Quantification of percentage of image occupied by FN fibrils. N = 1, n ³ 8 images for each
condition. (C) Quantification cell number. N = 1, n ³ 8 images for each condition. (D)
Quantification of average cell area. N = 1, n ³ 8 images for each condition.
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Quantification of FN dynamics and cell number, based on location, was performed by
dividing IF images into 5x5 grids and performing analysis separately in each binned
region. Frequency maps were then generated showcasing the average analysis in each
binned region (Fig. 5.7A). Data show that in the control alone, 0 ng/cm2 TGF-β1, there
was spatial patterning of FN fibrils, with the total FN fibril area being largest at the corners,
followed by the edges, and center. Spatially patterned FN was abrogated with TGF-β1
tethering, creating uniform accumulation of fibrils throughout the squares (Fig. 5.7B). Fibril
length, however, remained spatially patterned until the highest TGF-β1 surface
concentration, 500 ng/cm2, with longer fibrils assembling in the corners, followed by the
edges and center (Fig. 5.7C). Cell number was also consistently spatially patterned
throughout the entire range of TGF-β1 surface concentrations.

To determine the effect of TGF-β1 tethering to square islands without influence from FN
fibrils on spatial patterning, we cultured cells on tethered surfaces in the presence of FUD.
Results from IF indicated a notable difference in actin organization and adherens junction
assembly compared to cells cultured without the inhibitor. In these studies, actin began
to reorganize into stress fibers, and adherens junctions began to disassemble at a lower
surface concentration, 0.5 ng/cm2 TGF-β1. Interestingly, junction disassembly and actin
reorganization were not confined to the corner and edge regions. Full junctional
disassembly and actin reorganization into stress fibers throughout the entire square was
observed with 50 ng/cm2 TGF-β1 (Fig. 5.8A). Quantification of fibril assembly revealed a
low percentage of total image occupied by FN fibrils, with a sharp increase at 50 ng/cm2
TGF-β1. However, these values were lower in all surface concentrations than those in
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Figure 5.7. Microcontact printing TGF-β1 eliminates spatial patterning of FN fibril
area and enhances spatial patterning of FN fibril length and cell number in MCF10A
square islands with increasing surface density concentrations. (A) Representative
frequency maps of total FN fibril area per grid square, average FN fibril length per grid
square and cell number per grid square. (B) Quantification of total FN fibril area per grid
square based on TGF-β1 concentration and square location. N = 1, n ³ 8 images for each
condition. (C) Quantification of average FN fibril length per grid square based on TGF-β1
concentration and square location. N = 1, n ³ 8 images for each condition. (D)
Quantification of cell number area per grid square based on TGF-β1 concentration and
square location. N = 1, n ³ 8 images for each condition.
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500

Figure 5.8. Inhibition of FN fibrillogenesis reduces FN fibril assembly, decreases
cell number, and increases cell area in MCF10A square islands with increasing
surface density concentrations. (A) IF images of MCF10As treated with FUD and
cultured for 48 hours on square islands with increasing TGF-β1 surface density
concentrations. Ab staining for Nuclei (blue), FN (white), F-actin (red), and E-cadherin
(green). Scale bar 50 µm. (B) Quantification of percentage of image occupied by FN
fibrils. N = 1, n ³ 2 images for each condition. (C) Quantification cell number. N = 1, n ³ 2
images for each condition. (D) Quantification of average cell area. N = 1, n ³ 2 images
for each condition.
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conditions cultured without FUD (Fig. 5.8B). There was also a sharper decrease in cell
number and increase in cell size throughout the range of TGF-β1 surface concentrations
with FUD compared to without (Fig. 5.8C, D).

Again, to quantify FN dynamics and cell number, based on location, IF images were
divided into 5x5 grids, and analysis was performed separately in each binned region.
Frequency maps were then generated showcasing the average analysis in each binned
region (Fig. 5.9A). Total FN fibril area remained low and un-patterned until 50 ng/cm2
TGF-β1. Square islands tethered with 50 and 500 ng/cm2 TGF-β1 induced spatial
patterning of FN matrix in cells treated with FUD, with the highest level of FN at the
corners followed by the edges and center (Fig. 5.9B). Some patterning of fibril length
occurred throughout the range TGF-β1 surface concentrations with longer fibrils at the
corners as compared to the center, however, the lengths were very close to one another
regardless of location or surface concentration. The lengths were shorter overall than in
cells treated without FUD (Fig. 5.9C). Cell number remained spatially patterned in cells
treated with FUD, with more cells occupying the center, than at the edges and corners of
square islands (Fig. 5.9D).
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Figure 5.9. Inhibition of FN fibrillogenesis produces spatial patterning of FN fibril
area, reduces spatial patterning of FN fibril length, and enhances spatial patterning
of cell number in MCF10A square islands with increasing surface density
concentrations. (A) Representative frequency maps of total FN fibril area per grid
square, average FN fibril length per grid square and cell number per grid square. (B)
Quantification of total FN fibril area per grid square based on TGF-β1 concentration and
square location. N = 1, n ³ 2 images for each condition. (C) Quantification of average FN
fibril length per grid square based on TGF-β1 concentration and square location. N = 1,
n ³ 2 images for each condition. (D) Quantification of cell number area per grid square
based on TGF-β1 concentration and square location. N = 1, n ³ 2 images for each
condition.
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5.4. DISCUSSION

The interaction between mechanical and biochemical signaling is the key to truly
understanding cellular behavior. The ECM is often highlighted as a major regulator of
mechanical force in both physiology and pathology [7, 8]. As of late, extensive research
has been conducted to analyze the influence of both mechanical signaling and
biochemical signaling in EMT [5, 10, 11, 15, 16]. The work presented in this chapter
focused on one particular component of the ECM, FN fibrils, which integrated gf signaling
to induce coordinated changes in tissue geometry. Through FN assembly inhibition, we
showed that mammary epithelial cells were unable to spatially pattern morphological
transformations to the same degree as in the presence of fibrillogenesis with increasing
levels of soluble TGF-β1.

It was observed that at the highest dose of TGF-β1, 4 ng/mL, FN fibrils were ineffectively
inhibited, leading to a moderate phenotypic shift at corners and edges. These findings
support previous work highlighting intercellular tension as the main contributor of spatial
patterning of EMT along corners and edges of epithelial square islands [16]. It is possible
that the endogenous mechanical stress in these regions was large enough to promote
FN assembly even in the presence of a fibril inhibitor. Of particular interest was the fact
that fibrils remaining after FUD treatment were sufficiently colocalized with LTBP-1 in high
concentrations of TGF-β1. This accumulation of endogenous, latent TGF-β1 along fibrils
in the corners and edges of square islands could potentially exacerbate spatial patterning
due to the cells’ response to gf clustering in these regions.
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The concept of utilizing surface tethering to regulate spatial control of cellular processes
such as EMT has recently been employed in literature. In fact, re-organization of receptor
complexes through tethering of non-diffusible ligands to cell culture substrates has been
shown to sensitize and spatially regulate cells to low levels of endogenous TGF-β1 [168].
Our work utilizes surface tethering to probe the importance of gf/ECM interactions in
spatial patterning. Results from direct tethering of TGF-β1 to square islands support
previous findings that gf tethering to the ECM is an important component of signal
regulation [155].

There were several notable differences between cells treated with soluble TGF-β1 and
those cultured on immobilized TGF-β1 surfaces; primary differences being the overall
percent of images occupied by FN fibrils, and localization of FN matrix. Of interest was
that a surface concentration of 50 ng/cm2 was required to reach the equivalent percentage
of total image area occupied by FN fibrils, approximately 25%, as 4 ng/mL of soluble TGFβ1. This value translates to approximately 230 ng/mL of soluble TGF-β1 in bulk solution
for 48 hours. Two possible reasons behind this requirement for such a high surface
concentration could be that: 1) 50 ng/cm2 TGF-β1 covers approximately 10% of square
islands, therefore, only a limited number of cells are able to bind the immobilized TGFβ1, and 2) tethering of TGF-β1 to square islands lowers the rate of receptor/gf complex
endocytosis, limiting new receptor/gf interactions, and in turn delaying the signaling
cascade leading to fibrillogenesis. Although FN fibrils were not spatially patterned on
TGF-β1 tethered surfaces, fibril length was shown to be highest at the corners followed
by the edges and centers of square islands. Longer fibrils expose a larger number of
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cryptic binding sites for colocalization with endogenous, latent TGF-β1, therefore
increasing the potential for phenotypic transformation at corners and edges as compared
to centers of square islands. With fibril inhibition, on the other hand, there is less
competition between signaling directly from tethered TGF-β1 and FN matrix-localizedTGF-β1. This potentially explains why phenotypic transformation is not restricted to
corners and edges and can be seen throughout the entire square island in cells cultured
on tethered TGF-β1 surfaces in the presence of FUD.

Another approach to probing the importance of gf localization to the ECM in spatial
patterning would be to culture cells on pre-assembled FN matrices. As in studies
discussed in Chapters 4 and 5, cells would be cultured in square islands with 0, 2 and 4
ng/mL soluble TGF-β1 for 48 hours. Next, cells would be extracted, leaving behind the
FN matrix. New cells would then be cultured on these matrices and analysis would be
done to see whether TGF-β1 bound to these matrices would induce spatial patterning.
Other dynamics such as time needed for induction of spatial patterning would also be
analyzed.

The insights gained through this work suggest that tethering of TGF-β1 to FN matrix
facilitates localized signaling to induce spatial patterning. These studies serve as a
platform for future work aimed at understanding which components within the TGF-β1
signaling cascade are regulated by FN assembly. Obtaining a full picture for how FN
patterns gf signaling in both physiological and pathological processes can lead to
innovate therapies for development and disease.
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6.1. SUMMARY

The work presented in this thesis dissertation was an in-depth study of the interplay
between biomechanics and biochemistry in epithelial cell transformation. Fibronectin (FN)
matrices and Transforming Growth Factor-Beta1 (TGF-β1) provided a platform for
analysis of Epithelial to Mesenchymal Transition (EMT) and associated downstream
morphological changes. Exploration of this interaction was performed in three phases: 1)
examination of the effect of FN assembly inhibition on the induction of EMT; 2)
development of ideal substrates for repeatable measurements of TGF-β1-induced spatial
patterning of epithelial cell colonies; 3) Analysis of the role of FN in TGF-β1-induced
spatial patterning.

In Chapter 3, we examined the hypothesis that exogenous TGF-β1 increased contractile
forces, producing a FN matrix with exposed cryptic binding sites for localization of latent
TGF-β binding protein-1 (LTBP-1), in turn increasing concentration at the cell surface to
initiate the signaling cascade for EMT. Inhibition of of FN fibrillogeneisis lead to inhibition
of phenotypic transformation, TGF-β1 signaling, retention of cell size and cell density as
well as inhibition of increased migratory kinetics associated with TGF-β1-induced EMT.
Blocking localization of TGF-β1 to FN fibrils via a monoclonal blocking antibody and
mutation of the heparin-binding domain of FN blocked expression of mesenchymal
markers, as well as inhibited the phenotypic switch typically seen in TGF-β1-induced
EMT. These studies strongly suggest that FN fibril assembly is required for the induction
of EMT and downstream effects.
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Chapter 4 focused on a specific aspect of EMT, spatial patterning. Engineered square
islands allowed for examination of the effect of location dependence on ECM dynamics,
cell morphology transformation, and adherens junctional forces. Exposing cells to
increasing TGF-β1 concentrations created distinct spatial patterning of FN area, FN fibril
length, colocalization of LTBP-1 to FN fibrils, cell area and cell-cell junction formation,
with the largest areas of FN assembling in the corners, and most pronounced
morphological transformation, followed by edges and then centers. FRET intensity within
adherens junctions was also shown to be spatially patterned, suggesting a drop in force
within cell-cell junctions along the corners and edges of square islands of epithelial cells
exposed to increasing concentrations of TGF-β1 as compared to the center.

Building upon data presented in Chapter 4, Chapter 5 further fleshed out the role for FN
fibrillogenesis in TGF-β1-induced spatial patterning. Two methods were employed to do
so: 1) inhibition of FN fibril assembly, and 2) direct tethering of TGF-β1 to square island
surfaces. Inhibition of FN assembly was shown to diminish the spatial patterning seen in
Chapter 4. FN matrix, however, was retained in the corners of the square islands,
potentially suggesting higher mechanical forces within corners. In the absence of FN
fibrils, uniform distribution of TGF-β1 uniformly across square islands eliminated spatial
patterning of cell morphology, with cells equally exhibiting mesenchymal characteristics
throughout the entire square. These studies suggest that localization of TGF-β1 to FN
fibrils is key to the development of spatially patterned regions within epithelial tissue.
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Taken together, the three phases of this dissertation have given insights into the
functional and novel role for the FN matrix in TGF-β1 signaling. Therefore, this work has
the potential to provide further insight into developmental and pathological processes
associated with chemical/mechanical signal integration.
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6.2. FUTURE WORK

The work presented in this thesis dissertation is one piece of the story connecting the FN
matrix to TGF-β1-induced EMT, and there are several avenues for which this work may
be branched. Here, we discuss three potential areas for further investigation: 1) analysis
of cell-matrix and cell-cell junctional forces in TGF-β1-induced spatial patterning, 2)
examination of early events in epithelial monolayer formation, and 3) assessment of the
effect of island shape and size on TGF-β1-induced spatial patterning.

6.2.1. Assessment of the Effect of FN Fibril Assembly Inhibition on the Generation
of Cell-Matrix and Cell-Cell Junctional Forces in Epithelial Square Islands
Tissue stiffness has been recognized as an important modulator of EMT in mammary
epithelial cells. Previous studies have shown that mammary epithelial cells exposed to
TGF-β1 induce EMT on rigid surfaces and apoptosis on compliant surfaces [13]. It has
also been shown that FN fibril assembly requires the application of cellular contractile
forces to soluble FN [73, 150, 169] and that cells generate larger forces on stiffer surfaces
[170-172].

In Chapter 4, we showed that increasing TGF-β1 concentration shifted adherens
junctional force from being uniformly distributed across epithelial square islands to being
lowest at the corners compared to centers. The next logical step is to inhibit FN assembly
in the presence of increasing TGF-β1 concentration and determine the effect on force
distribution between adherens junctions and at the cell-matrix interface. Microfabricated
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grids of 2 µm circles, spaced 5 µm from center to center, in a 250 µm x 250 µm square
island would allow for analysis of spatial patterning of cell-traction force (Figure 6.1A).
Circle deflection would be optimized on a range of stiffnesses, representative of normal
to fibrotic breast tissue [113], to verify deflection detection over random noise. Varying
substrate stiffness would also allow for examination of the effect of matrix stiffness on
soluble signaling and patterning of epithelial cell transformation. Equation 6.1 would be
utilized to calculate cell traction force in real-time, based on the ECM dot’s centroidal
displacement vector (u), the dot radius (α) the Young’s Modulus of the substrate (E), and
the Poisson’s ratio of the material (ν), 0.5 for PDMS.

𝐹=

;/<=
[(@AB)(6DB)]

(6.1)

Analysis would be performed utilizing a previously generated algorithm in in MATLAB
[173-175]. We hypothesize that 1) force will first be lost at the cell-cell junctions, 2) force
will be transferred to adherens junctions via integrins and focal adhesions, 3) the actin
cytoskeleton will begin to reorganize into stress fibers, 4) FN will be assembled through
cell contractile forces, 5) in pathological environments, TGF-β1 will be able to localize to
FN fibrils and become activated to induce EMT. Therefore, this study will elucidate the
sequence of mechanical events leading to TGF-β1-induced spatial patterning of EMT.
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Figure 6.1 Method for analysis of cell traction force in square islands. (A)
Representative IF image of an array of 2 µm radius circles for calculations of cell traction
forces in a 250 µm x 250 µm square island. Ab staining for FN (white). Scale bar is 50
µm.
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6.2.2. Investigation of Early Events in Epithelial Sheet Formation
In addition to examination of spatial patterning of confluent epithelial colonies, it would be
of interest to investigate how the ECM facilitates early and middle-stage signaling events
in EMT. Preliminary studies revealed how epithelial cells oriented and reorganized over
a 24-hour period. Initially, cells assembled notable FN around the cell periphery, made
few cell-cell contacts, and exhibited an elongated morphology, with distinct F-actin stress
fibers (Fig. 6.2A). These results are in accordance with previous studies showing that
MCF10As undergo spontaneous EMT at low cell density [27]. As expected, cells became
more confluent within square islands over time (Fig. 6.2B). Quantification of cell area, cell
number, FN area, and colocalization of LTBP-1 with FN fibrils with respect to time could
be conducted in square islands of epithelial cells treated with and without TGF-β1.
Investigation into TGF-β1 influence would shed new light on the sequence of events
leading to FN matrix formation and cell morphology transformation in early stage spatial
patterning.

6.2.3. Analysis of Island Shape and Size in TGF-b1-Induced Spatial Patterning
Data from spatial patterning experiments could also be influenced by island shape and
size. In the context of blood vessel regeneration, previous research shows that island size
affects the efficiency at which endothelial cells differentiate. Endothelial cells confined to
smaller islands had a higher differentiation yield and a greater sprouting density than
those in larger islands [176]. In epithelial sheets, it has been shown that EMT marker
expression is restricted to high-stress regions in various shapes, such as corners and
edges of squares, and convex regions of sinusoidal monolayers [16]. EMT associated
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Figure 6.2 Spontaneous EMT/MET in square islands as a function of time. (A)
Representative IF images of MCF10As cultured under control conditions in 250 µm x 250
µm square islands over 24-Hours. Ab staining for F-actin (red), E-cadherin (green), and
FN (white). Scale bar is 50 µm. (B) Quantification of average confluence in MCF10As
cultured under standard conditions for 24 Hours. N = 1, n ³ 16 images for each condition.
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with tumor metastasis has been shown to be regulated by regions of low oxygen
distribution [177-179]. In contrast to data generated in 250 µm x 250 µm square islands,
future studies would employ 250 µm diameter circle islands for analysis of spatial
patterning (Figure 6.3A). Patterns of larger and smaller diameters such as 50 µm and
500 µm would allow for analysis of matrix dynamics and morphological transformations
based on geometry constriction. Additional studies involving varying cell shape and cell
size would therefore reveal how tissue geometry leads to EMT-permissive regions within
epithelial sheets.

The work presented in this thesis dissertation has exposed the FN matrix in a new light.
FN fibrils have been shown to serve as a scaffold for gf localization and are required for
adequate transformation of epithelial monolayers, particularly at colony boundaries. This
research is a tremendous step forward in our understanding of how ECM proteins are
involved in the initiation of EMT. By establishing a novel mechanism by which gf signaling
induces EMT through interaction with the extracellular matrix, this research identifies
novel targets within the microenvironment for regulation of diseases such as fibrosis, and
may serve to improve wound healing and cancer therapy.
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Figure 6.3 Tissue geometry effects on spatial patterning of FN matrix and cell
phenotype. (A) Representative images of MCF10As grown in standard culture conditions
for 24 Hours on circle islands. Scale bar is 50 µm.
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Commonwealth University Research Poster Symposium, Richmond VA,
Women in Engineering Best Poster Award, (2014)

§

Griggs, LA, Berrie, DM, Lemmon, CA, “The Role of Fibronectin Signaling
in Epithelial to Mesenchymal Transition,” Biomedical Engineering Society
Annual Meeting, Seattle WA, Innovation and Career Development Travel
Award, (2013)

AWARDS & HONORS
§ College of Engineering, Graduate Student Commencement
Speaker, Virginia Commonwealth University (2018)
§ Presidential Award for Community Multicultural Enrichment
(PACME): Student Award, Virginia Commonwealth University (2018)
§ 8th International EMT Meeting Travel Award, TEMTIA (2017)
§ 2017 BMES Annual Meeting Student Travel Award, BMES-NSBE
(2017)
§ Doctoral Scholars Dissertation Fellowship, Southern Regional
Education Board (2016)
§ Alex Clarke Award for Excellence in Biomedical Engineering,
Virginia Commonwealth University (2016)
§ Phi Kappa Phi Susan E. Kennedy Award, Virginia Commonwealth
University (2016)
§ Women in Engineering Best Poster, Virginia Commonwealth
University School of Engineering Research Poster Symposium (2014)
§ Honorable Mention, Ford Foundation Fellowship Program (2014)
§ Innovation and Career Development Travel Award, Biomedical
Engineering Society Meeting (2013)
§ Best Student Presentation Award, Virginia Academy of Science
Meeting (2013)
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PROFESSIONAL AFFILIATIONS
GENERAL MEMBERSHIP
§ The EMT International Association
§ American Society for Engineering Education
§ Biomedical Graduate Student Council, Virginia Commonwealth
University
§ Diversity Abroad Network
§ American Society for Matrix Biology
§ Honor Society of Phi Kappa Phi
§ The Black Graduate Student Association, Virginia Commonwealth
University
§ The Biomedical Engineering Society
§ The Virginia Academy of Science
§ Alpha Kappa Alpha Sorority, Inc.
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